| 1 |
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice. Cell Commun Signal. 2023 Nov 9;21(1):321.
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6770).
|
| 3 |
Alfuzosin FDA Label
|
| 4 |
2004 approvals: the demise of the blockbuster. Nat Rev Drug Discov. 2005 Feb;4(2):93-4.
|
| 5 |
Clinical pipeline report, company report or official report of Revo biologics.
|
| 6 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1084).
|
| 7 |
Betamethasone FDA Label
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
Cortisone acetate FDA Label
|
| 10 |
Cyclophosphamide FDA Label
|
| 11 |
2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
|
| 12 |
Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
|
| 13 |
Dexamethasone FDA Label
|
| 14 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026520)
|
| 15 |
Everolimus FDA Label
|
| 16 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 17 |
Fludarabine FDA Label
|
| 18 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1058).
|
| 19 |
Hydrocortisone FDA Label
|
| 20 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 21 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8339).
|
| 22 |
Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
|
| 23 |
FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 077090.
|
| 24 |
Methylprednisolone FDA Label
|
| 25 |
Methyltestosterone FDA Label
|
| 26 |
FDA Approved Drug Products from FDA Official Website.
|
| 27 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
|
| 28 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
|
| 29 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7637).
|
| 30 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2021
|
| 31 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2866).
|
| 32 |
Prednisone FDA Label
|
| 33 |
ClinicalTrials.gov (NCT01359943) Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
|
| 34 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
|
| 35 |
Sirolimus FDA Label
|
| 36 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7045).
|
| 37 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6844).
|
| 38 |
Testosterone FDA Label
|
| 39 |
Triamcinolone FDA Label
|
| 40 |
FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761238.
|
| 41 |
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008 Apr 15;14(8):2387-95.
|
| 42 |
New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21.
|
| 43 |
Improving compliance with interferon-beta therapy in patients with multiple sclerosis. CNS Drugs. 2009;23(6):453-62.
|
| 44 |
Emerging oral drugs for multiple sclerosis. Expert Opin Emerg Drugs. 2008 Sep;13(3):465-77.
|
| 45 |
ClinicalTrials.gov (NCT04586023) Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (FENhance). U.S. National Institutes of Health.
|
| 46 |
Multiple sclerosis: current and future treatment options. Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):292-9.
|
| 47 |
ClinicalTrials.gov (NCT00649428) Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles. U.S. National Institutes of Health.
|
| 48 |
ClinicalTrials.gov (NCT01695187) NB-001 Treatment of Recurrent Herpes Labialis. U.S. National Institutes of Health.
|
| 49 |
Clinical pipeline report, company report or official report of MolMed.
|
| 50 |
ClinicalTrials.gov (NCT01464905) Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS). U.S. National Institutes of Health.
|
| 51 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7544).
|
| 52 |
ClinicalTrials.gov (NCT04411641) A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis. U.S.National Institutes of Health.
|
| 53 |
ClinicalTrials.gov (NCT02869425) To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS. U.S. National Institutes of Health.
|
| 54 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 55 |
ClinicalTrials.gov (NCT01228396) AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis. U.S. National Institutes of Health.
|
| 56 |
Clinical pipeline report, company report or official report of Biogen Idec.
|
| 57 |
Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
|
| 58 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025673)
|
| 59 |
Clinical pipeline report, company report or official report of Allozyne Inc.
|
| 60 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038259)
|
| 61 |
ClinicalTrials.gov (NCT00382629) BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.
|
| 62 |
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. Neurol Neuroimmunol Neuroinflamm. 2014 Aug 21;1(2):e18.
|
| 63 |
Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
|
| 64 |
ClinicalTrials.gov (NCT03737812) A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis. U.S. National Institutes of Health.
|
| 65 |
ClinicalTrials.gov (NCT00001929) Treatment of Parkinson's Disease With Eliprodil. U.S. National Institutes of Health.
|
| 66 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018762)
|
| 67 |
A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
|
| 68 |
ClinicalTrials.gov (NCT04879628) A Phase 2, Double-blind, Randomized, Placebo-controlled Study Assessing Efficacy and Safety of SAR441344, a CD40L-antagonist Monoclonal Antibody, in Participants With Relapsing Multiple Sclerosis. U.S.National Institutes of Health.
|
| 69 |
Clinical pipeline report, company report or official report of Gemac Bio.
|
| 70 |
ClinicalTrials.gov (NCT01639300) Safety Study of GNbAC1 in Multiple Sclerosis Patients. U.S. National Institutes of Health.
|
| 71 |
Emerging drugs for spinal cord injury. Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80.
|
| 72 |
ClinicalTrials.gov (NCT01684761) Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis. U.S. National Institutes of Health.
|
| 73 |
ClinicalTrials.gov (NCT00239655) A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI). U.S. National Institutes of Health.
|
| 74 |
Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis. Expert Opin Emerg Drugs. 2009 Sep;14(3):471-9.
|
| 75 |
ClinicalTrials.gov (NCT01890655) Extension Study of MT-1303. U.S. National Institutes of Health.
|
| 76 |
ClinicalTrials.gov (NCT00001781) Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS). U.S. National Institutes of Health.
|
| 77 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021098)
|
| 78 |
ClinicalTrials.gov (NCT01963611) Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1). U.S. National Institutes of Health.
|
| 79 |
ClinicalTrials.gov (NCT01714089) Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.
|
| 80 |
ClinicalTrials.gov (NCT01008852) Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
|
| 81 |
ClinicalTrials.gov (NCT00245622) Autologous T Cell Vaccine (TCV) for Multiple Sclerosis. U.S. National Institutes of Health.
|
| 82 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013427)
|
| 83 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022066)
|
| 84 |
ClinicalTrials.gov (NCT02222948) Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis. U.S. National Institutes of Health.
|
| 85 |
ClinicalTrials.gov (NCT01259726) Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection. U.S. National Institutes of Health.
|
| 86 |
ClinicalTrials.gov (NCT01764737) Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS. U.S. National Institutes of Health.
|
| 87 |
ClinicalTrials.gov (NCT02173301) A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis. U.S. National Institutes of Health.
|
| 88 |
ClinicalTrials.gov (NCT01023256) Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
|
| 89 |
ClinicalTrials.gov (NCT01154387) Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection. U.S. National Institutes of Health.
|
| 90 |
Clinical pipeline report, company report or official report of Merck Serono.
|
| 91 |
ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile. PLoS One. 2014 Oct 27;9(10):e110819.
|
| 92 |
ClinicalTrials.gov (NCT02071121) Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect. U.S. National Institutes of Health.
|
| 93 |
ClinicalTrials.gov (NCT03943056) A Phase 1, Randomized, Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants. U.S.National Institutes of Health.
|
| 94 |
ClinicalTrials.gov (NCT04593121) A Phase 1, Randomized, Blinded, Placebo-Controlled, Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB107 in Healthy Adult Participants. U.S.National Institutes of Health.
|
| 95 |
ClinicalTrials.gov (NCT00616733) 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients. U.S. National Institutes of Health.
|
| 96 |
ClinicalTrials.gov (NCT01738347) Assess Safety, Bio-distribution, Dosimetry, and Optimize Imaging Protocol of GEH120714 (18F) Injection, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS). U.S. National Institutes of Health.
|
| 97 |
ClinicalTrials.gov (NCT01808482) A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS). U.S. National Institutes of Health.
|
| 98 |
ClinicalTrials.gov (NCT05131971) A Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3888130B in Healthy Participants Aged 18-55 Inclusive. U.S.National Institutes of Health.
|
| 99 |
ClinicalTrials.gov (NCT02282826) A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis. U.S. National Institutes of Health.
|
| 100 |
ClinicalTrials.gov (NCT01296386) An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84. U.S. National Institutes of Health.
|
| 101 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028859)
|
| 102 |
Antigen-Specific Blocking of CD4-Specific Immunological Synapse Formation Using BPI and Current Therapies for Autoimmune Diseases. Med Res Rev. 2012 July; 32(4): 727-764.
|
| 103 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032732)
|
| 104 |
Clinical pipeline report, company report or official report of Roche
|
| 105 |
ClinicalTrials.gov (NCT00411723) Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis. U.S. National Institutes of Health.
|
| 106 |
ClinicalTrials.gov (NCT00411723) Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis. U.S. National Institutes of Health.
|
| 107 |
Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2531-6.
|
| 108 |
Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
|
| 109 |
Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.
|
| 110 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016720)
|
| 111 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009065)
|
| 112 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009031)
|
| 113 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015672)
|
| 114 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008511)
|
| 115 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028330)
|
| 116 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007802)
|
| 117 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018778)
|
| 118 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7728).
|
| 119 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035649)
|
| 120 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024340)
|
| 121 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020823)
|
| 122 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012563)
|
| 123 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009742)
|
| 124 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013050)
|
| 125 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 126 |
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice. Eur J Pharmacol. 2017 May 5;802:76-84.
|
| 127 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032947)
|
| 128 |
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019 Apr;18(4):295-317.
|
| 129 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006361)
|
| 130 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021743)
|
| 131 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000987)
|
| 132 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030149)
|
| 133 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007767)
|
| 134 |
Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (E4). Nihon Rinsho. 2010 Jul;68 Suppl 7:448-61.
|
| 135 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 275).
|
| 136 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1870).
|
| 137 |
Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction.J Rheumatol. 2011 Sep;38(9):1866-70. doi: 10.3899/jrheum.110199. Epub 2011 Jul 15.
|
| 138 |
An immunogenetic heterogeneity in multiple sclerosis.J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):887-90. doi: 10.1136/jnnp.55.10.887.
|
| 139 |
The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.J Immunol. 1998 Apr 1;160(7):3543-54.
|
| 140 |
Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression.J Immunol. 2000 Dec 1;165(11):6576-82. doi: 10.4049/jimmunol.165.11.6576.
|
| 141 |
Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.J Neuroimmunol. 2001 May 1;116(1):116-24. doi: 10.1016/s0165-5728(01)00283-1.
|
| 142 |
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.Neurochem Res. 2015 Nov;40(11):2333-47. doi: 10.1007/s11064-015-1723-x. Epub 2015 Sep 23.
|
| 143 |
Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors.Tissue Antigens. 2000 Mar;55(3):199-205. doi: 10.1034/j.1399-0039.2000.550302.x.
|
| 144 |
Protective effects of CX3CR1 on autoimmune inflammation in a chronic EAE model for MS through modulation of antigen-presenting cell-related molecular MHC-II and its regulators.Neurol Sci. 2019 Apr;40(4):779-791. doi: 10.1007/s10072-019-3721-2. Epub 2019 Jan 23.
|
| 145 |
Pathological roles of the homeostatic chemokine CXCL12.Cytokine Growth Factor Rev. 2018 Dec;44:51-68. doi: 10.1016/j.cytogfr.2018.10.004. Epub 2018 Oct 23.
|
| 146 |
Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.J Neuroinflammation. 2019 Mar 11;16(1):59. doi: 10.1186/s12974-019-1440-5.
|
| 147 |
Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.Int J Mol Sci. 2019 Jan 30;20(3):602. doi: 10.3390/ijms20030602.
|
| 148 |
MAIT cell subtypes in multiple sclerosis.J Neuroimmunol. 2020 Feb 15;339:577117. doi: 10.1016/j.jneuroim.2019.577117. Epub 2019 Nov 20.
|
| 149 |
The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.Mol Neurobiol. 2018 Jan;55(1):462-469. doi: 10.1007/s12035-016-0325-1. Epub 2016 Dec 13.
|
| 150 |
Multiple sclerosis treatment effects on plasma cytokine receptor levels.Clin Immunol. 2018 Feb;187:15-25. doi: 10.1016/j.clim.2017.08.023. Epub 2017 Sep 21.
|
| 151 |
Association between the gamma-aminobutyric acid A3 receptor gene and multiple sclerosis.Arch Neurol. 1998 Apr;55(4):513-6. doi: 10.1001/archneur.55.4.513.
|
| 152 |
GPR17 receptor modulators and their therapeutic implications: review of recent patents.Expert Opin Ther Pat. 2019 Feb;29(2):85-95. doi: 10.1080/13543776.2019.1568990. Epub 2019 Jan 24.
|
| 153 |
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.PLoS One. 2019 Feb 15;14(2):e0212357. doi: 10.1371/journal.pone.0212357. eCollection 2019.
|
| 154 |
Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiation.J Clin Immunol. 2002 May;22(3):153-63. doi: 10.1023/a:1015472013500.
|
| 155 |
Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.Sci Rep. 2019 Sep 10;9(1):12994. doi: 10.1038/s41598-019-49385-6.
|
| 156 |
V delta 1 gene usage, interleukin-2 receptors and adhesion molecules on gamma delta+ T cells in inflammatory diseases of the nervous system.J Neuroimmunol. 1994 Jan;49(1-2):59-66. doi: 10.1016/0165-5728(94)90181-3.
|
| 157 |
B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LT and TGF1 response.J Neuroimmunol. 2018 Nov 15;324:157-164. doi: 10.1016/j.jneuroim.2018.09.001. Epub 2018 Sep 7.
|
| 158 |
A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions.J Neurochem. 1999 Dec;73(6):2531-7. doi: 10.1046/j.1471-4159.1999.0732531.x.
|
| 159 |
NCAM1 is the Target of miRNA-572: Validation in the Human Oligodendroglial Cell Line.Cell Mol Neurobiol. 2018 Mar;38(2):431-440. doi: 10.1007/s10571-017-0486-0. Epub 2017 Mar 22.
|
| 160 |
Analysis of NOD-like receptor NLRP1 in multiple sclerosis families.Immunogenetics. 2018 Mar;70(3):205-207. doi: 10.1007/s00251-017-1034-2. Epub 2017 Oct 7.
|
| 161 |
Association between the phenylethanolamine N-methyltransferase gene and multiple sclerosis.J Neuroimmunol. 2002 Mar;124(1-2):101-5. doi: 10.1016/s0165-5728(02)00009-7.
|
| 162 |
Melanocortin receptor subtypes are expressed on cells in the oligodendroglial lineage and signal ACTH protection.J Neurosci Res. 2018 Mar;96(3):427-435. doi: 10.1002/jnr.24141. Epub 2017 Sep 6.
|
| 163 |
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.Hum Immunol. 2003 Feb;64(2):274-84. doi: 10.1016/s0198-8859(02)00804-2.
|
| 164 |
miR-140-5p regulates T cell differentiation and attenuates experimental autoimmune encephalomyelitis by affecting CD4(+)T cell metabolism and DNA methylation.Int Immunopharmacol. 2019 Oct;75:105778. doi: 10.1016/j.intimp.2019.105778. Epub 2019 Sep 5.
|
| 165 |
Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions.J Neuropathol Exp Neurol. 2019 Jun 1;78(6):492-500. doi: 10.1093/jnen/nlz030.
|
| 166 |
Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis.J Neuroimmunol. 2003 May;138(1-2):115-22. doi: 10.1016/s0165-5728(03)00090-0.
|
| 167 |
The T-cell receptor beta locus and susceptibility to multiple sclerosis.Neurology. 1995 Oct;45(10):1859-63. doi: 10.1212/wnl.45.10.1859.
|
| 168 |
Therapeutic potential of tyrosine kinase 2 in autoimmunity.Expert Opin Ther Targets. 2014 May;18(5):571-80. doi: 10.1517/14728222.2014.892925. Epub 2014 Mar 21.
|
| 169 |
Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter.Mult Scler. 2006 Aug;12(4):386-96. doi: 10.1191/135248506ms1300oa.
|
| 170 |
IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis.Genes Immun. 2005 Mar;6(2):153-61. doi: 10.1038/sj.gene.6364164.
|
| 171 |
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.J Neuropathol Exp Neurol. 2006 Sep;65(9):855-65. doi: 10.1097/01.jnen.0000235119.52311.16.
|
| 172 |
Interferon-gamma mRNA attenuates its own translation by activating PKR: a molecular basis for the therapeutic effect of interferon-beta in multiple sclerosis.Cell Res. 2006 Feb;16(2):148-53. doi: 10.1038/sj.cr.7310020.
|
| 173 |
Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions.J Neuroimmunol. 2005 Jan;158(1-2):182-90. doi: 10.1016/j.jneuroim.2004.08.012.
|
| 174 |
Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.Genes Immun. 2006 Jun;7(4):310-5. doi: 10.1038/sj.gene.6364299. Epub 2006 Apr 20.
|
| 175 |
Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis.J Neuroimmunol. 2005 Apr;161(1-2):195-8. doi: 10.1016/j.jneuroim.2004.12.014.
|
| 176 |
Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.Neurobiol Dis. 2005 Apr;18(3):537-50. doi: 10.1016/j.nbd.2004.10.007.
|
| 177 |
Increased expression and function of glutamate transporters in multiple sclerosis.Neurobiol Dis. 2006 Jan;21(1):154-64. doi: 10.1016/j.nbd.2005.06.017. Epub 2005 Aug 2.
|
| 178 |
Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers.Sci Transl Med. 2019 Nov 13;11(518):eaaw0475. doi: 10.1126/scitranslmed.aaw0475.
|
| 179 |
CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.Oncol Rep. 2012 Aug;28(2):465-72. doi: 10.3892/or.2012.1831. Epub 2012 May 24.
|
| 180 |
The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.Curr Drug Targets. 2016;17(6):651-65. doi: 10.2174/1389450117666160201105934.
|
| 181 |
How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression.J Vis Exp. 2017 Jan 23;(119):55100. doi: 10.3791/55100.
|
| 182 |
Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.PLoS Genet. 2019 Jan 17;15(1):e1007808. doi: 10.1371/journal.pgen.1007808. eCollection 2019 Jan.
|
| 183 |
Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF- therapy.IUBMB Life. 2016 Sep;68(9):727-34. doi: 10.1002/iub.1530. Epub 2016 Jun 27.
|
| 184 |
LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.Mol Neurobiol. 2017 Aug;54(6):4365-4378. doi: 10.1007/s12035-016-9994-z. Epub 2016 Jun 25.
|
| 185 |
Expressions of IGF-1, ERK, GLUT4, IRS-1 in metabolic syndrome complicated with colorectal cancer and their associations with the clinical characteristics of CRC.Cancer Biomark. 2018;21(4):883-891. doi: 10.3233/CBM-170942.
|
| 186 |
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.Malar J. 2008 Dec 11;7:251. doi: 10.1186/1475-2875-7-251.
|
| 187 |
Genetic variants regulate NR1H3 expression and contribute to multiple sclerosis risk.J Neurol Sci. 2018 Jul 15;390:162-165. doi: 10.1016/j.jns.2018.04.037. Epub 2018 Apr 22.
|
| 188 |
Targeting P2X4 and P2X7 receptors in multiple sclerosis.Curr Opin Pharmacol. 2019 Aug;47:119-125. doi: 10.1016/j.coph.2019.03.010. Epub 2019 Apr 20.
|
| 189 |
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.Bioorg Med Chem. 2017 May 1;25(9):2643-2656. doi: 10.1016/j.bmc.2017.03.006. Epub 2017 Mar 6.
|
| 190 |
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.Int J Immunogenet. 2015 Apr;42(2):106-10. doi: 10.1111/iji.12183. Epub 2015 Feb 12.
|
| 191 |
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis.Eur J Neurol. 2020 Feb;27(2):221-228. doi: 10.1111/ene.14105. Epub 2019 Nov 6.
|
| 192 |
Serum levels of LIGHT in MS.Mult Scler. 2013 Jun;19(7):871-6. doi: 10.1177/1352458512463766. Epub 2012 Oct 4.
|
| 193 |
UCP2 up-regulation within the course of autoimmune encephalomyelitis correlates with T-lymphocyte activation.Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):1002-1012. doi: 10.1016/j.bbadis.2017.01.019. Epub 2017 Jan 25.
|
| 194 |
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.J Neuroinflammation. 2018 Mar 1;15(1):64. doi: 10.1186/s12974-018-1103-y.
|
| 195 |
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.Neuropharmacology. 2018 Oct;141:181-191. doi: 10.1016/j.neuropharm.2018.08.038. Epub 2018 Aug 30.
|
| 196 |
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.Brain. 2014 May;137(Pt 5):1454-69. doi: 10.1093/brain/awu045. Epub 2014 Mar 12.
|
| 197 |
Mitochondrial complex enzyme activities and cytochrome C expression changes in multiple sclerosis.Mol Neurobiol. 2014 Feb;49(1):1-9. doi: 10.1007/s12035-013-8481-z. Epub 2013 Jun 13.
|
| 198 |
Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment.J Neuroimmunol. 2009 May 29;210(1-2):108-12. doi: 10.1016/j.jneuroim.2009.02.008. Epub 2009 Mar 25.
|
| 199 |
PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis.J Mol Neurosci. 2019 Jul;68(3):439-451. doi: 10.1007/s12031-018-1137-8. Epub 2018 Jul 30.
|
| 200 |
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions.Front Immunol. 2019 Apr 24;10:855. doi: 10.3389/fimmu.2019.00855. eCollection 2019.
|
| 201 |
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.J Neuroimmune Pharmacol. 2020 Jun;15(2):249-263. doi: 10.1007/s11481-019-09894-7. Epub 2019 Dec 11.
|
| 202 |
Potential role of calcifying nanoparticles in the etiology of multiple sclerosis.Med Hypotheses. 2019 Jul;128:25-27. doi: 10.1016/j.mehy.2019.05.005. Epub 2019 May 11.
|
| 203 |
Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda(-/-) and Ung(-/-) Mice.J Immunol. 2018 Aug 15;201(4):1119-1130. doi: 10.4049/jimmunol.1700729. Epub 2018 Jul 6.
|
| 204 |
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.Eur J Immunol. 2016 Mar;46(3):570-81. doi: 10.1002/eji.201545782. Epub 2016 Jan 22.
|
| 205 |
Angiopoietin-like proteins in multiple sclerosis.J Neuroimmunol. 2019 May 15;330:31-34. doi: 10.1016/j.jneuroim.2019.02.006. Epub 2019 Feb 15.
|
| 206 |
Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.PLoS One. 2018 Feb 2;13(2):e0192109. doi: 10.1371/journal.pone.0192109. eCollection 2018.
|
| 207 |
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke?.Thromb Haemost. 2019 Jan;119(1):175-178. doi: 10.1055/s-0038-1676346. Epub 2018 Dec 31.
|
| 208 |
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Acta Neuropathol. 2017 Jan;133(1):61-77. doi: 10.1007/s00401-016-1621-6. Epub 2016 Oct 4.
|
| 209 |
Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.Mol Neurobiol. 2019 Dec;56(12):8589-8602. doi: 10.1007/s12035-019-01691-w. Epub 2019 Jul 6.
|
| 210 |
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.Brain. 2013 Jan;136(Pt 1):106-15. doi: 10.1093/brain/aws325.
|
| 211 |
Acid sensing ion channel 2: A new potential player in the pathophysiology of multiple sclerosis.Eur J Neurosci. 2019 May;49(10):1233-1243. doi: 10.1111/ejn.14302. Epub 2019 Feb 19.
|
| 212 |
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609.
|
| 213 |
Butyrylcholinesterase activity in multiple sclerosis neuropathology.Chem Biol Interact. 2010 Sep 6;187(1-3):425-31. doi: 10.1016/j.cbi.2010.01.037. Epub 2010 Feb 1.
|
| 214 |
Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability.Arch Neurol. 2005 May;62(5):795-800. doi: 10.1001/archneur.62.5.795.
|
| 215 |
Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions.Am J Pathol. 2019 Mar;189(3):665-676. doi: 10.1016/j.ajpath.2018.11.007. Epub 2018 Dec 13.
|
| 216 |
Risk alleles for multiple sclerosis identified by a genomewide study.N Engl J Med. 2007 Aug 30;357(9):851-62. doi: 10.1056/NEJMoa073493. Epub 2007 Jul 29.
|
| 217 |
A non-functional galanin receptor-2 in a multiple sclerosis patient.Pharmacogenomics J. 2019 Feb;19(1):72-82. doi: 10.1038/s41397-018-0032-6. Epub 2018 Aug 22.
|
| 218 |
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.Sci Rep. 2016 Jul 14;6:29699. doi: 10.1038/srep29699.
|
| 219 |
Genetic modifiers of multiple sclerosis progression, severity and onset.Clin Immunol. 2017 Jul;180:100-105. doi: 10.1016/j.clim.2017.05.009. Epub 2017 May 10.
|
| 220 |
Inflammasome Proteins As Biomarkers of Multiple Sclerosis.Front Neurol. 2018 Mar 19;9:135. doi: 10.3389/fneur.2018.00135. eCollection 2018.
|
| 221 |
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):367-76. doi: 10.1007/s00005-015-0339-9. Epub 2015 May 10.
|
| 222 |
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.J Neurol Sci. 2008 Apr 15;267(1-2):86-90. doi: 10.1016/j.jns.2007.10.001. Epub 2007 Oct 29.
|
| 223 |
Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study.Hum Genet. 2005 Oct;118(1):67-75. doi: 10.1007/s00439-005-0003-2. Epub 2005 Aug 3.
|
| 224 |
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.J Neuroimmunol. 2014 Nov 15;276(1-2):187-94. doi: 10.1016/j.jneuroim.2014.08.620. Epub 2014 Aug 27.
|
| 225 |
Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.Brain. 2019 Apr 1;142(4):916-931. doi: 10.1093/brain/awz012.
|
| 226 |
Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.J Neuroimmune Pharmacol. 2019 Sep;14(3):413-422. doi: 10.1007/s11481-018-09832-z. Epub 2019 Jan 16.
|
| 227 |
Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.Immunology. 2017 Apr;150(4):444-455. doi: 10.1111/imm.12696. Epub 2017 Jan 3.
|
| 228 |
CD1A and CD1E gene polymorphisms are associated with susceptibility to multiple sclerosis.Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):175-83. doi: 10.1177/039463201102400120.
|
| 229 |
Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene.Int J Nanomedicine. 2017 Aug 3;12:5557-5569. doi: 10.2147/IJN.S140734. eCollection 2017.
|
| 230 |
Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.Neuroimmunomodulation. 2018;25(4):185-192. doi: 10.1159/000489561. Epub 2018 Nov 13.
|
| 231 |
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets.PLoS One. 2015 Jun 11;10(6):e0130126. doi: 10.1371/journal.pone.0130126. eCollection 2015.
|
| 232 |
Altered Expression of miR-326 in T Cell-derived Exosomes of Patients with Relapsing-remitting Multiple Sclerosis.Iran J Allergy Asthma Immunol. 2019 Feb;18(1):108-113.
|
| 233 |
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.Am J Pathol. 2008 Jan;172(1):146-55. doi: 10.2353/ajpath.2008.070690. Epub 2007 Dec 21.
|
| 234 |
Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.Mult Scler. 2019 Dec;25(14):1942-1945. doi: 10.1177/1352458518810261. Epub 2018 Nov 7.
|
| 235 |
Analysis of chosen SNVs in GPC5, CD58 and IRF8 genes in multiple sclerosis patients.Adv Med Sci. 2019 Sep;64(2):230-234. doi: 10.1016/j.advms.2018.12.004. Epub 2019 Feb 26.
|
| 236 |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.
|
| 237 |
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.J Neuroimmunol. 2015 Nov 15;288:79-86. doi: 10.1016/j.jneuroim.2015.09.004. Epub 2015 Sep 18.
|
| 238 |
The levels of soluble forms of CD21 and CD83 in multiple sclerosis.J Neuroimmunol. 2018 Jul 15;320:11-14. doi: 10.1016/j.jneuroim.2018.04.005. Epub 2018 Apr 13.
|
| 239 |
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.Brain. 2018 Mar 1;141(3):786-796. doi: 10.1093/brain/awx372.
|
| 240 |
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.
|
| 241 |
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.Sci Rep. 2016 Jul 20;6:29847. doi: 10.1038/srep29847.
|
| 242 |
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.PLoS One. 2013 Jun 19;8(6):e65936. doi: 10.1371/journal.pone.0065936. Print 2013.
|
| 243 |
Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Sci Rep. 2017 Jun 2;7(1):2707. doi: 10.1038/s41598-017-03027-x.
|
| 244 |
Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity.Mult Scler Relat Disord. 2019 Feb;28:34-43. doi: 10.1016/j.msard.2018.11.032. Epub 2018 Dec 5.
|
| 245 |
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.Sci Rep. 2019 May 9;9(1):7178. doi: 10.1038/s41598-019-43428-8.
|
| 246 |
Transketolase and 2',3'-cyclic-nucleotide 3'-phosphodiesterase type I isoforms are specifically recognized by IgG autoantibodies in multiple sclerosis patients.Mol Cell Proteomics. 2008 Dec;7(12):2337-49. doi: 10.1074/mcp.M700277-MCP200. Epub 2008 Jul 31.
|
| 247 |
Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?.Drug Discov Today. 2019 Sep;24(9):1845-1853. doi: 10.1016/j.drudis.2019.05.023. Epub 2019 May 31.
|
| 248 |
Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.J Mol Neurosci. 2020 Jan;70(1):26-31. doi: 10.1007/s12031-019-01395-9. Epub 2019 Aug 13.
|
| 249 |
Anti-neurofascin autoantibody and demyelination.Neurochem Int. 2019 Nov;130:104360. doi: 10.1016/j.neuint.2018.12.011. Epub 2018 Dec 22.
|
| 250 |
Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis.Clin Epigenetics. 2019 May 30;11(1):86. doi: 10.1186/s13148-019-0678-1.
|
| 251 |
The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation.Nat Commun. 2015 Jun 2;6:7216. doi: 10.1038/ncomms8216.
|
| 252 |
Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine Stimulate a Common Immune Suppressive Pathway with Implications for Future Therapies.Cold Spring Harb Perspect Med. 2019 Jul 1;9(7):a034223. doi: 10.1101/cshperspect.a034223.
|
| 253 |
Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.J Neuroimmunol. 2018 Apr 15;317:45-54. doi: 10.1016/j.jneuroim.2017.12.017. Epub 2017 Dec 22.
|
| 254 |
Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.Pain. 2019 Sep;160(9):2050-2062. doi: 10.1097/j.pain.0000000000001596.
|
| 255 |
Cathepsin H deficiency in mice induces excess Th1 cell activation and early-onset of EAE though impairment of toll-like receptor 3 cascade.Inflamm Res. 2018 May;67(5):371-374. doi: 10.1007/s00011-018-1136-9. Epub 2018 Feb 22.
|
| 256 |
CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.Adv Clin Exp Med. 2018 Jun;27(6):849-856. doi: 10.17219/acem/68846.
|
| 257 |
Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement.J Spinal Cord Med. 2021 May;44(3):411-417. doi: 10.1080/10790268.2019.1666238. Epub 2019 Sep 26.
|
| 258 |
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.Immunol Invest. 2013;42(8):737-48. doi: 10.3109/08820139.2013.812652. Epub 2013 Jul 22.
|
| 259 |
A genetic link between CXCR5 and IL2RA gene polymorphisms and susceptibility to multiple sclerosis.Neurol Res. 2018 Dec;40(12):1040-1047. doi: 10.1080/01616412.2018.1517110.
|
| 260 |
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.J Neuroimmunol. 2010 Oct 8;227(1-2):162-6. doi: 10.1016/j.jneuroim.2010.06.003. Epub 2010 Jul 2.
|
| 261 |
Enantioselectivity in the Metabolism of Cyclophosphamide in Patients With Multiple or Systemic Sclerosis.J Clin Pharmacol. 2017 Jun;57(6):784-795. doi: 10.1002/jcph.863. Epub 2017 Jan 13.
|
| 262 |
Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.Sci Rep. 2017 Jun 2;7(1):2702. doi: 10.1038/s41598-017-02638-8.
|
| 263 |
DDIT4 and Associated lncDDIT4 Modulate Th17 Differentiation through the DDIT4/TSC/mTOR Pathway.J Immunol. 2018 Mar 1;200(5):1618-1626. doi: 10.4049/jimmunol.1601689. Epub 2018 Jan 29.
|
| 264 |
Measurement of the permeability, perfusion, and histogram characteristics in relapsing-remitting multiple sclerosis using dynamic contrast-enhanced MRI with extended Tofts linear model.Neurol India. 2018 May-Jun;66(3):709-715. doi: 10.4103/0028-3886.232324.
|
| 265 |
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Oncotarget. 2017 Jul 4;8(27):44266-44280. doi: 10.18632/oncotarget.17863.
|
| 266 |
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?.Int J Biochem Cell Biol. 2015 Oct;67:49-57. doi: 10.1016/j.biocel.2015.05.010. Epub 2015 May 19.
|
| 267 |
Diversity of V delta-J delta gene rearrangement in peripheral blood lymphocytes and intrathecal IgG synthesis in multiple sclerosis.Folia Neuropathol. 1999;37(2):113-6.
|
| 268 |
DNase hypersensitive sites and association with multiple sclerosis.Hum Mol Genet. 2014 Feb 15;23(4):942-8. doi: 10.1093/hmg/ddt489. Epub 2013 Oct 2.
|
| 269 |
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.Brain. 2012 Jun;135(Pt 6):1794-818. doi: 10.1093/brain/aws100. Epub 2012 Apr 28.
|
| 270 |
EGFL7 reduces CNS inflammation in mouse.Nat Commun. 2018 Feb 26;9(1):819. doi: 10.1038/s41467-018-03186-z.
|
| 271 |
Activating transcription factor 6 deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.Glia. 2018 Jul;66(7):1331-1345. doi: 10.1002/glia.23307. Epub 2018 Feb 13.
|
| 272 |
Identification of the miRNA-mRNA regulatory network in multiple sclerosis.Neurol Res. 2017 Feb;39(2):142-151. doi: 10.1080/01616412.2016.1250857. Epub 2016 Nov 4.
|
| 273 |
Characterization of residue-specific glutathionylation of CSF proteins in multiple sclerosis - A MS-based approach.Anal Biochem. 2019 Jan 1;564-565:108-115. doi: 10.1016/j.ab.2018.10.015. Epub 2018 Oct 24.
|
| 274 |
A functional variant in ERAP1 predisposes to multiple sclerosis.PLoS One. 2012;7(1):e29931. doi: 10.1371/journal.pone.0029931. Epub 2012 Jan 12.
|
| 275 |
Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis.Front Genet. 2018 Feb 16;9:42. doi: 10.3389/fgene.2018.00042. eCollection 2018.
|
| 276 |
Toll-like receptor 4 and protease-activated receptor 2 in physiology and pathophysiology of the nervous system: more than just receptor cooperation?.Neural Regen Res. 2019 Jul;14(7):1196-1201. doi: 10.4103/1673-5374.251290.
|
| 277 |
Association of circulating anti-CD64 IgM levels with favourable long-term clinical outcomes in multiple sclerosis patients.J Neuroimmunol. 2019 May 15;330:130-135. doi: 10.1016/j.jneuroim.2019.03.005. Epub 2019 Mar 8.
|
| 278 |
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.J Neuropathol Exp Neurol. 2013 Feb;72(2):106-18. doi: 10.1097/NEN.0b013e31827fd9e8.
|
| 279 |
Fingolimod Suppresses the Proinflammatory Status of Interferon--Activated Cultured Rat Astrocytes.Mol Neurobiol. 2019 Sep;56(9):5971-5986. doi: 10.1007/s12035-019-1481-x. Epub 2019 Jan 30.
|
| 280 |
Accessible exercise equipment and individuals with multiple sclerosis: Aerobic demands and preferences.NeuroRehabilitation. 2019;45(3):359-367. doi: 10.3233/NRE-192861.
|
| 281 |
Calcitriol, but not FGF23, increases in CSF and serum of MS patients.J Neuroimmunol. 2019 Mar 15;328:89-93. doi: 10.1016/j.jneuroim.2018.12.011. Epub 2018 Dec 30.
|
| 282 |
Assessment of Protein Prenylation Pathway in Multiple Sclerosis Patients.J Mol Neurosci. 2018 Apr;64(4):581-590. doi: 10.1007/s12031-018-1052-z. Epub 2018 Mar 25.
|
| 283 |
Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.J Neuroinflammation. 2019 Dec 3;16(1):252. doi: 10.1186/s12974-019-1612-3.
|
| 284 |
Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.Life Sci. 2019 Jul 15;229:116-123. doi: 10.1016/j.lfs.2019.05.021. Epub 2019 May 10.
|
| 285 |
The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis.Mult Scler Relat Disord. 2019 Feb;28:75-80. doi: 10.1016/j.msard.2018.12.019. Epub 2018 Dec 14.
|
| 286 |
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment.PLoS One. 2013;8(2):e57655. doi: 10.1371/journal.pone.0057655. Epub 2013 Feb 28.
|
| 287 |
Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients.J Neuropathol Exp Neurol. 2019 Jun 1;78(6):480-491. doi: 10.1093/jnen/nlz028.
|
| 288 |
Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis.Arch Phys Med Rehabil. 2018 Oct;99(10):2045-2049. doi: 10.1016/j.apmr.2018.05.029. Epub 2018 Jun 30.
|
| 289 |
Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.Neural Regen Res. 2018 Mar;13(3):393-401. doi: 10.4103/1673-5374.228712.
|
| 290 |
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.Sci Rep. 2019 Nov 21;9(1):17309. doi: 10.1038/s41598-019-54032-1.
|
| 291 |
Specific Alterations in Astrocyte Properties via the GluA2-GAPDH Complex Associated with Multiple Sclerosis.Sci Rep. 2018 Aug 27;8(1):12856. doi: 10.1038/s41598-018-31318-4.
|
| 292 |
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.Pharmacol Ther. 2018 Aug;188:97-117. doi: 10.1016/j.pharmthera.2018.03.002. Epub 2018 Mar 4.
|
| 293 |
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.Mult Scler. 2020 Feb;26(2):210-219. doi: 10.1177/1352458518819380. Epub 2018 Dec 20.
|
| 294 |
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.J Neuropathol Exp Neurol. 2014 Sep;73(9):865-79. doi: 10.1097/NEN.0000000000000106.
|
| 295 |
Connexin 43/47 channels are important for astrocyte/ oligodendrocyte cross-talk in myelination and demyelination.J Biosci. 2018 Dec;43(5):1055-1068. doi: 10.1007/s12038-018-9811-0.
|
| 296 |
Usefulness of lyso-globotriaosylsphingosine in dried blood spots in the differential diagnosis between multiple sclerosis and Anderson-Fabry's disease.Mult Scler Relat Disord. 2020 Feb;38:101466. doi: 10.1016/j.msard.2019.101466. Epub 2019 Oct 23.
|
| 297 |
A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.PLoS One. 2014 Jun 26;9(6):e100883. doi: 10.1371/journal.pone.0100883. eCollection 2014.
|
| 298 |
EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4T Cells.Cell Rep. 2017 Jan 31;18(5):1270-1284. doi: 10.1016/j.celrep.2017.01.020.
|
| 299 |
Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis.Bioorg Med Chem. 2017 Jan 15;25(2):483-495. doi: 10.1016/j.bmc.2016.11.015. Epub 2016 Nov 18.
|
| 300 |
Glutamate, T cells and multiple sclerosis.J Neural Transm (Vienna). 2017 Jul;124(7):775-798. doi: 10.1007/s00702-016-1661-z. Epub 2017 Feb 24.
|
| 301 |
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.PLoS One. 2013 Jun 28;8(6):e67357. doi: 10.1371/journal.pone.0067357. Print 2013.
|
| 302 |
A single nucleotide polymorphism in the metabotropic glutamate receptor 7 gene is associated with multiple sclerosis in Iranian population.Mult Scler Relat Disord. 2019 Feb;28:189-192. doi: 10.1016/j.msard.2019.01.012. Epub 2019 Jan 3.
|
| 303 |
Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b(+)Gr-1(+) Myeloid Cells.Front Immunol. 2018 Apr 24;9:873. doi: 10.3389/fimmu.2018.00873. eCollection 2018.
|
| 304 |
Erythropoietin Upregulates Brain Hemoglobin Expression and Supports Neuronal Mitochondrial Activity.Mol Neurobiol. 2018 Oct;55(10):8051-8058. doi: 10.1007/s12035-018-0971-6. Epub 2018 Mar 1.
|
| 305 |
Dimethyl fumarate downregulates the immune response through the HCA(2)/GPR109A pathway: Implications for the treatment of multiple sclerosis.Mult Scler Relat Disord. 2018 Jul;23:46-50. doi: 10.1016/j.msard.2018.04.016. Epub 2018 Apr 25.
|
| 306 |
Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis. Eur J Neurol. 2010 Feb;17(2):335-8.
|
| 307 |
Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis.J Neuroimmunol. 2014 Dec 15;277(1-2):186-8. doi: 10.1016/j.jneuroim.2014.09.018. Epub 2014 Sep 28.
|
| 308 |
Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.PLoS One. 2017 Dec 18;12(12):e0189380. doi: 10.1371/journal.pone.0189380. eCollection 2017.
|
| 309 |
Levels of 17-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis.Biomark Med. 2018 Dec;12(12):1331-1340. doi: 10.2217/bmm-2018-0061. Epub 2018 Dec 6.
|
| 310 |
Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.Clin Exp Immunol. 2018 Nov;194(2):137-152. doi: 10.1111/cei.13186. Epub 2018 Sep 19.
|
| 311 |
Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.J Clin Invest. 2009 Jan;119(1):169-81. doi: 10.1172/JCI35440. Epub 2008 Dec 22.
|
| 312 |
Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases.J Clin Endocrinol Metab. 2014 May;99(5):E796-803. doi: 10.1210/jc.2013-3072. Epub 2014 Feb 11.
|
| 313 |
Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.J Immunol. 2017 Mar 1;198(5):1900-1909. doi: 10.4049/jimmunol.1601139. Epub 2017 Jan 27.
|
| 314 |
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.BMC Genet. 2016 Apr 14;17:59. doi: 10.1186/s12863-016-0367-4.
|
| 315 |
Association of the IL-10 receptor A536G (S138G) loss-of-function variant with multiple sclerosis in Tunisian patients.APMIS. 2017 May;125(5):444-451. doi: 10.1111/apm.12659. Epub 2017 Feb 22.
|
| 316 |
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.Mult Scler. 2020 Sep;26(10):1172-1186. doi: 10.1177/1352458519852092. Epub 2019 Jun 25.
|
| 317 |
IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis.J Immunol. 2015 Mar 1;194(5):2099-109. doi: 10.4049/jimmunol.1401547. Epub 2015 Jan 23.
|
| 318 |
The IL-12 cytokine family in cardiovascular diseases.Cytokine. 2019 Oct;122:154188. doi: 10.1016/j.cyto.2017.10.010. Epub 2017 Oct 23.
|
| 319 |
The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.Gene. 2019 Feb 15;685:164-169. doi: 10.1016/j.gene.2018.11.006. Epub 2018 Nov 3.
|
| 320 |
Impact of interferon -1b, interferon -1a and fingolimod therapies on serum interleukins-22, 32 and 34 concentrations in patients with relapsing-remitting multiple sclerosis.J Neuroimmunol. 2019 Dec 15;337:577062. doi: 10.1016/j.jneuroim.2019.577062. Epub 2019 Sep 6.
|
| 321 |
Clinical and Serological Biomarkers of Treatment's Response in Multiple Sclerosis Patients Treated Continuously with Interferon-1b for More than a Decade.CNS Neurol Disord Drug Targets. 2018;17(10):780-792. doi: 10.2174/1871527317666180917095256.
|
| 322 |
Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients.Curr Mol Med. 2019;19(5):357-363. doi: 10.2174/1566524019666190405120137.
|
| 323 |
CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.Mol Neurobiol. 2019 Dec;56(12):7977-7993. doi: 10.1007/s12035-019-1640-0. Epub 2019 Jun 2.
|
| 324 |
Th9 cells in the pathogenesis of EAE and multiple sclerosis.Semin Immunopathol. 2017 Jan;39(1):79-87. doi: 10.1007/s00281-016-0604-y. Epub 2016 Nov 14.
|
| 325 |
Association between miRNA-146a and Polymorphisms of its Target Gene, IRAK1, Regarding Susceptibility to and Clinical Features of Systemic Lupus Erythematous and Multiple Sclerosis.Lab Med. 2019 Jan 1;50(1):34-41. doi: 10.1093/labmed/lmy033.
|
| 326 |
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.Clin Exp Immunol. 2012 Nov;170(2):149-55. doi: 10.1111/j.1365-2249.2012.04654.x.
|
| 327 |
Effects of intestinal nematode treatment on CD11b activation state in an EAE mouse model of multiple sclerosis.Immunobiology. 2019 Nov;224(6):817-826. doi: 10.1016/j.imbio.2019.08.004. Epub 2019 Aug 13.
|
| 328 |
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.Mult Scler. 2016 Dec;22(14):1783-1793. doi: 10.1177/1352458516635873. Epub 2016 Feb 26.
|
| 329 |
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.J Immunol. 2007 Oct 1;179(7):4563-70. doi: 10.4049/jimmunol.179.7.4563.
|
| 330 |
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.Brain Res. 2013 Nov 6;1537:340-9. doi: 10.1016/j.brainres.2013.09.024. Epub 2013 Sep 23.
|
| 331 |
The K(2P) -channel TASK1 affects Oligodendroglial differentiation but not myelin restoration.Glia. 2019 May;67(5):870-883. doi: 10.1002/glia.23577. Epub 2019 Jan 9.
|
| 332 |
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.J Neuroimmunol. 2016 May 15;294:1-5. doi: 10.1016/j.jneuroim.2016.03.007. Epub 2016 Mar 18.
|
| 333 |
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.Mult Scler. 2012 Jul;18(7):951-8. doi: 10.1177/1352458511431726. Epub 2011 Dec 20.
|
| 334 |
Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release.Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):271-276. doi: 10.1073/pnas.1810020116. Epub 2018 Dec 17.
|
| 335 |
NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.Front Immunol. 2019 Feb 6;10:154. doi: 10.3389/fimmu.2019.00154. eCollection 2019.
|
| 336 |
Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis.Biochem Genet. 2019 Jun;57(3):355-370. doi: 10.1007/s10528-018-9894-1. Epub 2018 Nov 19.
|
| 337 |
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.J Neurol. 1995 Oct;242(10):677-82. doi: 10.1007/BF00866919.
|
| 338 |
Evaluation of mutual interference between bovine -lactalbumin peptide and its isotope-labeled peptide in whey protein analysis using liquid chromatography-tandem mass spectrometry.J Chromatogr A. 2018 Jan 19;1533:94-101. doi: 10.1016/j.chroma.2017.12.024. Epub 2017 Dec 9.
|
| 339 |
Herpes viruses in optic neuritis: Similar to Bell's palsy.Clin Neurol Neurosurg. 2020 Jan;188:105588. doi: 10.1016/j.clineuro.2019.105588. Epub 2019 Nov 5.
|
| 340 |
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.Int J Neurosci. 2016;126(3):205-12. doi: 10.3109/00207454.2015.1007508. Epub 2015 Jun 16.
|
| 341 |
Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.Neurotherapeutics. 2017 Jan;14(1):199-211. doi: 10.1007/s13311-016-0480-0.
|
| 342 |
Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.J Biomol Screen. 2016 Jun;21(5):437-45. doi: 10.1177/1087057116638821. Epub 2016 Mar 16.
|
| 343 |
Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.PLoS One. 2014 Dec 31;9(12):e115488. doi: 10.1371/journal.pone.0115488. eCollection 2014.
|
| 344 |
Genetic basis for relapse rate in multiple sclerosis: Association with LRP2 genetic variation.Mult Scler. 2018 Nov;24(13):1773-1775. doi: 10.1177/1352458517749894. Epub 2018 Jan 5.
|
| 345 |
The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.Clin Exp Immunol. 2017 Jul;189(1):120-126. doi: 10.1111/cei.12954. Epub 2017 Mar 28.
|
| 346 |
Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.Mult Scler. 2020 Aug;26(9):1102-1110. doi: 10.1177/1352458519852722. Epub 2019 Jun 4.
|
| 347 |
Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis.Neurobiol Dis. 2019 Jul;127:87-100. doi: 10.1016/j.nbd.2019.02.018. Epub 2019 Feb 25.
|
| 348 |
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.Sci Adv. 2016 Jun 17;2(6):e1501678. doi: 10.1126/sciadv.1501678. eCollection 2016 Jun.
|
| 349 |
Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.Neurosci Lett. 2020 Jan 10;715:134599. doi: 10.1016/j.neulet.2019.134599. Epub 2019 Nov 10.
|
| 350 |
Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype.Front Immunol. 2019 Oct 4;10:2312. doi: 10.3389/fimmu.2019.02312. eCollection 2019.
|
| 351 |
Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.J Neuroinflammation. 2018 Aug 22;15(1):236. doi: 10.1186/s12974-018-1276-4.
|
| 352 |
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.PLoS Genet. 2016 Mar 18;12(3):e1005853. doi: 10.1371/journal.pgen.1005853. eCollection 2016 Mar.
|
| 353 |
Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.Genes Immun. 2014 Apr;15(4):218-23. doi: 10.1038/gene.2014.7. Epub 2014 Feb 27.
|
| 354 |
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.Front Neurol. 2018 Dec 18;9:1080. doi: 10.3389/fneur.2018.01080. eCollection 2018.
|
| 355 |
Metabolic defects in multiple sclerosis.Mitochondrion. 2019 Jan;44:7-14. doi: 10.1016/j.mito.2017.12.005. Epub 2017 Dec 13.
|
| 356 |
Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.Genes Immun. 2009 Oct;10(7):631-5. doi: 10.1038/gene.2009.56. Epub 2009 Aug 6.
|
| 357 |
Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.J Neuroimmunol. 2012 Sep 15;250(1-2):106-10. doi: 10.1016/j.jneuroim.2012.05.014. Epub 2012 Jun 13.
|
| 358 |
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.J Neurol Sci. 2014 Oct 15;345(1-2):248-51. doi: 10.1016/j.jns.2014.07.045. Epub 2014 Jul 30.
|
| 359 |
Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis.Neurol Sci. 2019 Feb;40(2):385-391. doi: 10.1007/s10072-018-3660-3. Epub 2018 Dec 1.
|
| 360 |
Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis.J Cell Biochem. 2019 Apr;120(4):5160-5168. doi: 10.1002/jcb.27792. Epub 2018 Oct 15.
|
| 361 |
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity.PLoS Biol. 2019 Sep 16;17(9):e3000451. doi: 10.1371/journal.pbio.3000451. eCollection 2019 Sep.
|
| 362 |
Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.Int J Neurosci. 2019 Dec;129(12):1256-1260. doi: 10.1080/00207454.2019.1660655. Epub 2019 Sep 2.
|
| 363 |
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis.Mult Scler Relat Disord. 2019 Jan;27:294-297. doi: 10.1016/j.msard.2018.11.011. Epub 2018 Nov 13.
|
| 364 |
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.Mult Scler. 2013 Nov;19(13):1696-703. doi: 10.1177/1352458513482512. Epub 2013 Apr 2.
|
| 365 |
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.Hum Mol Genet. 2014 Apr 1;23(7):1916-22. doi: 10.1093/hmg/ddt574. Epub 2013 Nov 13.
|
| 366 |
Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity.Front Immunol. 2017 Oct 13;8:1319. doi: 10.3389/fimmu.2017.01319. eCollection 2017.
|
| 367 |
Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.Neurosci Lett. 2017 May 10;649:100-106. doi: 10.1016/j.neulet.2017.04.005. Epub 2017 Apr 6.
|
| 368 |
Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?.Eur J Neurol. 2017 Sep;24(9):1108-1115. doi: 10.1111/ene.13340. Epub 2017 Jul 5.
|
| 369 |
The role of vitamin D and P2X7R in multiple sclerosis.J Neuroimmunol. 2019 May 15;330:159-169. doi: 10.1016/j.jneuroim.2019.03.004. Epub 2019 Mar 14.
|
| 370 |
Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.Exp Ther Med. 2019 Nov;18(5):4113-4119. doi: 10.3892/etm.2019.8005. Epub 2019 Sep 13.
|
| 371 |
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.J Asthma. 2017 Jan 2;54(1):46-52. doi: 10.1080/02770903.2016.1196366. Epub 2016 Jun 10.
|
| 372 |
InCl(3) mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis.Eur J Med Chem. 2019 Jul 15;174:198-215. doi: 10.1016/j.ejmech.2019.04.020. Epub 2019 Apr 16.
|
| 373 |
Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.Sci Rep. 2017 Mar 3;7:43545. doi: 10.1038/srep43545.
|
| 374 |
Significance of elevated Prohibitin 1 levels in Multiple Sclerosis patients lymphocytes towards the assessment of subclinical disease activity and its role in the central nervous system pathology of disease.Int J Biol Macromol. 2018 Apr 15;110:573-581. doi: 10.1016/j.ijbiomac.2017.12.061. Epub 2017 Dec 11.
|
| 375 |
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS.Cell. 2019 Dec 12;179(7):1483-1498.e22. doi: 10.1016/j.cell.2019.11.016. Epub 2019 Dec 5.
|
| 376 |
Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.Neurol Sci. 2017 May;38(5):865-872. doi: 10.1007/s10072-017-2857-1. Epub 2017 Feb 22.
|
| 377 |
Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML.J Neurol. 2018 Aug;265(8):1880-1882. doi: 10.1007/s00415-018-8931-7. Epub 2018 Jun 15.
|
| 378 |
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.Metab Brain Dis. 2015 Feb;30(1):57-65. doi: 10.1007/s11011-014-9558-8. Epub 2014 May 9.
|
| 379 |
NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms.Biochim Biophys Acta Proteins Proteom. 2019 Jul-Aug;1867(7-8):663-676. doi: 10.1016/j.bbapap.2019.05.002. Epub 2019 May 12.
|
| 380 |
Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.PLoS One. 2017 Jul 31;12(7):e0182069. doi: 10.1371/journal.pone.0182069. eCollection 2017.
|
| 381 |
Microsomal Prostaglandin E Synthase-1 Facilitates an Intercellular Interaction between CD4?T Cells through IL-1 Autocrine Function in Experimental Autoimmune Encephalomyelitis.Int J Mol Sci. 2017 Dec 19;18(12):2758. doi: 10.3390/ijms18122758.
|
| 382 |
MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2).Biochem Biophys Res Commun. 2017 May 6;486(3):759-766. doi: 10.1016/j.bbrc.2017.03.115. Epub 2017 Mar 23.
|
| 383 |
Impact of vitamin A supplementation on RAR gene expression in multiple sclerosis patients.J Mol Neurosci. 2013 Oct;51(2):478-84. doi: 10.1007/s12031-013-0090-9. Epub 2013 Aug 17.
|
| 384 |
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy.PLoS One. 2015 Apr 8;10(4):e0119605. doi: 10.1371/journal.pone.0119605. eCollection 2015.
|
| 385 |
miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.Immunogenetics. 2019 Feb;71(2):87-95. doi: 10.1007/s00251-018-1087-x. Epub 2018 Oct 11.
|
| 386 |
Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.Cell Death Dis. 2018 Oct 17;9(11):1061. doi: 10.1038/s41419-018-1118-4.
|
| 387 |
A genome-wide association study of brain lesion distribution in multiple sclerosis.Brain. 2013 Apr;136(Pt 4):1012-24. doi: 10.1093/brain/aws363. Epub 2013 Feb 13.
|
| 388 |
SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing.J Neurol Sci. 2017 Apr 15;375:198-202. doi: 10.1016/j.jns.2017.01.069. Epub 2017 Jan 27.
|
| 389 |
The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker.Pharmacogenomics J. 2020 Apr;20(2):271-276. doi: 10.1038/s41397-019-0114-0. Epub 2019 Oct 24.
|
| 390 |
Up-regulation of PGC-1 in neurons protects against experimental autoimmune encephalomyelitis.FASEB J. 2019 Dec;33(12):14811-14824. doi: 10.1096/fj.201901149RR. Epub 2019 Nov 13.
|
| 391 |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.Genet Epidemiol. 2019 Oct;43(7):844-863. doi: 10.1002/gepi.22242. Epub 2019 Aug 13.
|
| 392 |
Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system.Sci Rep. 2017 Aug 21;7(1):8958. doi: 10.1038/s41598-017-09405-9.
|
| 393 |
Is There Any Relevance Between Serum Heavy Metal Concentration and BBB Leakage in Multiple Sclerosis Patients?.Biol Trace Elem Res. 2019 Aug;190(2):289-294. doi: 10.1007/s12011-018-1553-1. Epub 2018 Oct 27.
|
| 394 |
Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.Pain. 2020 Jan;161(1):177-184. doi: 10.1097/j.pain.0000000000001697.
|
| 395 |
Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.Neurobiol Dis. 2019 Apr;124:189-201. doi: 10.1016/j.nbd.2018.11.018. Epub 2018 Nov 22.
|
| 396 |
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date.Drug Des Devel Ther. 2017 Nov 2;11:3153-3157. doi: 10.2147/DDDT.S122249. eCollection 2017.
|
| 397 |
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.Neurology. 2016 Feb 2;86(5):410-7. doi: 10.1212/WNL.0000000000002326. Epub 2016 Jan 6.
|
| 398 |
Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis.Front Mol Neurosci. 2019 Aug 27;12:190. doi: 10.3389/fnmol.2019.00190. eCollection 2019.
|
| 399 |
Semaphorin-3A as An Immune Modulator Is Suppressed by MicroRNA-145-5p.Cell J. 2018 Apr;20(1):113-119. doi: 10.22074/cellj.2018.4842. Epub 2017 Dec 1.
|
| 400 |
Cerebrospinal fluid complement system biomarkers in demyelinating disease.Mult Scler. 2020 Dec;26(14):1929-1937. doi: 10.1177/1352458519887905. Epub 2019 Nov 8.
|
| 401 |
Rab32 connects ER stress to mitochondrial defects in multiple sclerosis.J Neuroinflammation. 2017 Jan 23;14(1):19. doi: 10.1186/s12974-016-0788-z.
|
| 402 |
Salt, inflammatory joint disease, and autoimmunity.Joint Bone Spine. 2018 Jul;85(4):411-416. doi: 10.1016/j.jbspin.2017.06.003. Epub 2017 Jun 23.
|
| 403 |
Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics.ACS Chem Biol. 2017 Oct 20;12(10):2671-2681. doi: 10.1021/acschembio.7b00581. Epub 2017 Sep 20.
|
| 404 |
Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes.Rev Neurosci. 2018 Jan 26;29(1):39-53. doi: 10.1515/revneuro-2017-0033.
|
| 405 |
Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.J Clin Invest. 2019 May 21;129(8):3277-3292. doi: 10.1172/JCI124012.
|
| 406 |
Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis.Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):317-323. doi: 10.1016/j.bbadis.2017.09.024. Epub 2017 Sep 28.
|
| 407 |
Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis.Neuromodulation. 2018 Jun;21(4):383-389. doi: 10.1111/ner.12583. Epub 2017 Feb 22.
|
| 408 |
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.BMC Med Genet. 2012 Aug 10;13:70. doi: 10.1186/1471-2350-13-70.
|
| 409 |
Absence of system x(c)(-) on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.J Neuroinflammation. 2017 Jan 13;14(1):9. doi: 10.1186/s12974-016-0787-0.
|
| 410 |
Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.Mult Scler Relat Disord. 2019 Feb;28:44-49. doi: 10.1016/j.msard.2018.11.024. Epub 2018 Nov 30.
|
| 411 |
Novel SNARE Complex Polymorphisms Associated with Multiple Sclerosis: Signs of Synaptopathy in Multiple Sclerosis.Balkan Med J. 2019 May 10;36(3):174-178. doi: 10.4274/balkanmedj.galenos.2018.2017.1034. Epub 2018 Dec 24.
|
| 412 |
MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.J Neuroinflammation. 2017 Mar 16;14(1):55. doi: 10.1186/s12974-017-0832-7.
|
| 413 |
Role of Sortilin in Models of Autoimmune Neuroinflammation.J Immunol. 2015 Dec 15;195(12):5762-9. doi: 10.4049/jimmunol.1403156. Epub 2015 Nov 13.
|
| 414 |
Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines.Methods Mol Biol. 2018;1697:43-56. doi: 10.1007/7651_2017_44.
|
| 415 |
FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.J Lipid Res. 2019 Jul;60(7):1311-1322. doi: 10.1194/jlr.M093799. Epub 2019 May 20.
|
| 416 |
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis.J Neuroimmunol. 2020 Jan 15;338:577107. doi: 10.1016/j.jneuroim.2019.577107. Epub 2019 Nov 7.
|
| 417 |
The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.Nat Commun. 2016 Jul 15;7:12073. doi: 10.1038/ncomms12073.
|
| 418 |
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.Mult Scler. 2014 Aug;20(9):1171-81. doi: 10.1177/1352458514521516. Epub 2014 Feb 13.
|
| 419 |
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Sci Rep. 2017 Jan 24;7:41271. doi: 10.1038/srep41271.
|
| 420 |
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-s, Claudin-11, and Matrix Metalloproteinase-2.Cell Mol Neurobiol. 2016 Aug;36(6):865-872. doi: 10.1007/s10571-015-0270-y. Epub 2016 Jan 14.
|
| 421 |
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon- therapy.Neuroimmunomodulation. 2012;19(5):283-92. doi: 10.1159/000336981. Epub 2012 Apr 3.
|
| 422 |
A Fas(hi) Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation.Front Immunol. 2017 Feb 14;8:97. doi: 10.3389/fimmu.2017.00097. eCollection 2017.
|
| 423 |
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.Front Immunol. 2019 Apr 30;10:835. doi: 10.3389/fimmu.2019.00835. eCollection 2019.
|
| 424 |
Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity.J Neuroimmunol. 2017 Apr 15;305:131-134. doi: 10.1016/j.jneuroim.2017.02.008. Epub 2017 Feb 7.
|
| 425 |
Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis.Autoimmun Rev. 2020 Jan;19(1):102430. doi: 10.1016/j.autrev.2019.102430. Epub 2019 Nov 15.
|
| 426 |
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients.Clin Immunol. 2014 Jul;153(1):211-9. doi: 10.1016/j.clim.2014.04.016. Epub 2014 May 9.
|
| 427 |
1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo.PLoS One. 2013;8(3):e58808. doi: 10.1371/journal.pone.0058808. Epub 2013 Mar 14.
|
| 428 |
Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.Metab Brain Dis. 2016 Feb;31(1):197-204. doi: 10.1007/s11011-015-9788-4. Epub 2016 Jan 8.
|
| 429 |
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.J Neuropathol Exp Neurol. 2008 Dec;67(12):1137-48. doi: 10.1097/NEN.0b013e31818dab90.
|
| 430 |
B cells in MS and NMO: pathogenesis and therapy.Semin Immunopathol. 2014 May;36(3):339-50. doi: 10.1007/s00281-014-0424-x. Epub 2014 May 16.
|
| 431 |
Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.PLoS One. 2012;7(11):e47578. doi: 10.1371/journal.pone.0047578. Epub 2012 Nov 30.
|
| 432 |
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis.J Transl Med. 2019 Feb 20;17(1):51. doi: 10.1186/s12967-019-1789-3.
|
| 433 |
Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.Clin Immunol. 2018 Feb;187:95-101. doi: 10.1016/j.clim.2017.10.009. Epub 2017 Oct 25.
|
| 434 |
Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.J Neuroimmunol. 2019 Oct 15;335:577020. doi: 10.1016/j.jneuroim.2019.577020. Epub 2019 Aug 14.
|
| 435 |
Prevalence of celiac disease in multiple sclerosis.BMC Neurol. 2011 Mar 7;11:31. doi: 10.1186/1471-2377-11-31.
|
| 436 |
Tripeptidyl-peptidase II: Update on an oldie that still counts.Biochimie. 2019 Nov;166:27-37. doi: 10.1016/j.biochi.2019.05.012. Epub 2019 May 17.
|
| 437 |
Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis.J Pathol. 2019 Apr;247(4):471-480. doi: 10.1002/path.5205. Epub 2019 Jan 30.
|
| 438 |
TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.J Neurosci. 2018 Sep 26;38(39):8484-8495. doi: 10.1523/JNEUROSCI.2203-17.2018. Epub 2018 Sep 10.
|
| 439 |
The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response.FASEB J. 2018 Mar;32(3):1236-1249. doi: 10.1096/fj.201700552R. Epub 2018 Jan 3.
|
| 440 |
Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [(18)F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.Mol Imaging Biol. 2019 Oct;21(5):935-944. doi: 10.1007/s11307-019-01323-8.
|
| 441 |
Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis.J Mol Recognit. 2019 Dec;32(12):e2807. doi: 10.1002/jmr.2807. Epub 2019 Aug 6.
|
| 442 |
The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.Glia. 2018 Oct;66(10):2209-2220. doi: 10.1002/glia.23481. Epub 2018 Sep 12.
|
| 443 |
Plasma VCAM1 levels correlate with disease severity in Parkinson's disease.J Neuroinflammation. 2019 May 8;16(1):94. doi: 10.1186/s12974-019-1482-8.
|
| 444 |
A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitis.J Neuroinflammation. 2019 Jul 30;16(1):161. doi: 10.1186/s12974-019-1548-7.
|
| 445 |
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves.FASEB J. 2008 Aug;22(8):2970-80. doi: 10.1096/fj.08-106666. Epub 2008 Apr 15.
|
| 446 |
Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.Mult Scler. 2008 Jun;14(5):577-94. doi: 10.1177/1352458507087468.
|
| 447 |
Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.J Neuroimmunol. 2009 Aug 18;213(1-2):142-7. doi: 10.1016/j.jneuroim.2009.05.010. Epub 2009 Jun 9.
|
| 448 |
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Int J Mol Sci. 2017 Nov 2;18(11):2306. doi: 10.3390/ijms18112306.
|
| 449 |
Altered expression patterns of complement factor H and miR-146a genes in acute-chronic phases in experimental autoimmune encephalomyelitis mouse.J Cell Physiol. 2019 Nov;234(11):19842-19851. doi: 10.1002/jcp.28583. Epub 2019 Apr 10.
|
| 450 |
Hygiene hypothesis: innate immunity, malaria and multiple sclerosis.Med Hypotheses. 2008;70(4):819-25. doi: 10.1016/j.mehy.2006.10.069. Epub 2007 Sep 21.
|
| 451 |
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals.Hum Mol Genet. 2010 Nov 1;19(21):4286-95. doi: 10.1093/hmg/ddq328. Epub 2010 Aug 10.
|
| 452 |
The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.Free Radic Biol Med. 2011 Aug 1;51(3):713-8. doi: 10.1016/j.freeradbiomed.2011.04.043. Epub 2011 May 5.
|
| 453 |
Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.Int Immunol. 2010 Sep;22(9):729-38. doi: 10.1093/intimm/dxq059. Epub 2010 Aug 3.
|
| 454 |
Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study.Br J Clin Pharmacol. 2019 Aug;85(8):1719-1727. doi: 10.1111/bcp.13955. Epub 2019 Jun 4.
|
| 455 |
Genetic analysis of an allergic rhinitis cohort reveals an intercellular epistasis between FAM134B and CD39.BMC Med Genet. 2014 Jun 27;15:73. doi: 10.1186/1471-2350-15-73.
|
| 456 |
Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?.Mult Scler. 2007 May;13(4):446-53. doi: 10.1177/13524585070130040201.
|
| 457 |
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.PLoS One. 2011;6(12):e29648. doi: 10.1371/journal.pone.0029648. Epub 2011 Dec 27.
|
| 458 |
Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.Neuropharmacology. 2008 Sep;55(4):491-9. doi: 10.1016/j.neuropharm.2008.06.066. Epub 2008 Jul 8.
|
| 459 |
Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice.Cell Mol Immunol. 2020 Oct;17(10):1077-1091. doi: 10.1038/s41423-019-0274-5. Epub 2019 Aug 29.
|
| 460 |
Mode of Action of Aspirin in Experimental Autoimmune Encephalomyelitis.DNA Cell Biol. 2019 Jul;38(7):593-596. doi: 10.1089/dna.2019.4814. Epub 2019 May 28.
|
| 461 |
Preliminary study: treatment with intramuscular interferon beta-1a results in increased levels of IL-12R2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis.BMC Neurol. 2011 Dec 19;11:155. doi: 10.1186/1471-2377-11-155.
|
| 462 |
IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.Am J Pathol. 2011 Feb;178(2):794-802. doi: 10.1016/j.ajpath.2010.10.043.
|
| 463 |
Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients.Cytokine. 2020 Feb;126:154911. doi: 10.1016/j.cyto.2019.154911. Epub 2019 Nov 12.
|
| 464 |
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.Ann Neurol. 2018 Jul;84(1):51-63. doi: 10.1002/ana.25263. Epub 2018 Jul 3.
|
| 465 |
Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.Mol Immunol. 2011 Sep;48(15-16):1896-902. doi: 10.1016/j.molimm.2011.05.018. Epub 2011 Jun 12.
|
| 466 |
Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis.Glia. 2018 Feb;66(2):359-378. doi: 10.1002/glia.23249. Epub 2017 Oct 31.
|
| 467 |
Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.J Neuroimmunol. 2007 Feb;183(1-2):175-88. doi: 10.1016/j.jneuroim.2006.09.014. Epub 2006 Nov 16.
|
| 468 |
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.J Neuroimmunol. 2012 May 15;246(1-2):51-7. doi: 10.1016/j.jneuroim.2012.03.003. Epub 2012 Mar 27.
|
| 469 |
Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy.Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E181-E190. doi: 10.1073/pnas.1617115114. Epub 2017 Jan 3.
|
| 470 |
Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.Brain Behav Immun. 2018 Feb;68:44-55. doi: 10.1016/j.bbi.2017.09.015. Epub 2017 Sep 27.
|
| 471 |
Characterization of multiple sclerosis traits: nuclear receptors (NR) impaired apoptosis pathway and the role of 1- 25-dihydroxyvitamin D3.J Neurol Sci. 2011 Dec 15;311(1-2):9-14. doi: 10.1016/j.jns.2011.06.038. Epub 2011 Jul 12.
|
| 472 |
Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes.Nat Commun. 2019 Mar 13;10(1):1139. doi: 10.1038/s41467-019-08976-7.
|
| 473 |
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.Hum Mol Genet. 2014 Dec 20;23(25):6746-61. doi: 10.1093/hmg/ddu392. Epub 2014 Jul 30.
|
| 474 |
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.Hum Genet. 2010 Mar;127(5):525-35. doi: 10.1007/s00439-010-0789-4. Epub 2010 Jan 30.
|
| 475 |
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.PLoS One. 2010 Feb 18;5(2):e9287. doi: 10.1371/journal.pone.0009287.
|
| 476 |
Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis.Neurology. 2007 Jan 23;68(4):283-7. doi: 10.1212/01.wnl.0000252357.30287.1d.
|
| 477 |
Sodium channel expression within chronic multiple sclerosis plaques.J Neuropathol Exp Neurol. 2007 Sep;66(9):828-37. doi: 10.1097/nen.0b013e3181462841.
|
| 478 |
A Review on Clinical Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Natalizumab: A Humanized Anti-4 Integrin Monoclonal Antibody.Curr Drug Metab. 2018;19(14):1213-1223. doi: 10.2174/1389200219666180427165841.
|
| 479 |
Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.J Leukoc Biol. 2009 Nov;86(5):1049-63. doi: 10.1189/jlb.1008666. Epub 2009 Aug 20.
|
| 480 |
Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis.Cells. 2019 Sep 10;8(9):1058. doi: 10.3390/cells8091058.
|
| 481 |
Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition.Genes Immun. 2011 Mar;12(2):145-8. doi: 10.1038/gene.2010.42. Epub 2010 Oct 21.
|
| 482 |
The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis.Scand J Immunol. 2007 May;65(5):461-6. doi: 10.1111/j.1365-3083.2007.01921.x.
|
| 483 |
TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.PLoS Med. 2007 Apr;4(4):e124. doi: 10.1371/journal.pmed.0040124.
|
| 484 |
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.Neurology. 2011 Mar 22;76(12):1059-65. doi: 10.1212/WNL.0b013e318211c3c8. Epub 2011 Feb 23.
|
| 485 |
Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjgren's syndrome.Eur J Immunol. 2005 Jan;35(1):305-17. doi: 10.1002/eji.200425406.
|
| 486 |
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.J Exp Med. 2006 Feb 20;203(2):425-35. doi: 10.1084/jem.20052148. Epub 2006 Feb 13.
|
| 487 |
Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions. Mol Neurobiol. 2017 Nov;54(9):6820-6826.
|
| 488 |
Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions.Stem Cells Int. 2019 Apr 30;2019:5496891. doi: 10.1155/2019/5496891. eCollection 2019.
|
| 489 |
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.Cell Adh Migr. 2012 May-Jun;6(3):179-89. doi: 10.4161/cam.20341. Epub 2012 May 1.
|
| 490 |
The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.Int J Mol Sci. 2017 Sep 28;18(10):2070. doi: 10.3390/ijms18102070.
|
| 491 |
Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.Stem Cells Transl Med. 2018 Oct;7(10):748-758. doi: 10.1002/sctm.18-0045. Epub 2018 Jul 31.
|
| 492 |
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?.Biochim Biophys Acta. 2011 Feb;1812(2):162-76. doi: 10.1016/j.bbadis.2010.07.016. Epub 2010 Aug 6.
|
| 493 |
A homozygous genetic variant of mitochondrial uncoupling protein 4 exerts protection against the occurrence of multiple sclerosis.Neuromolecular Med. 2009;11(2):101-5. doi: 10.1007/s12017-009-8071-4. Epub 2009 Jun 18.
|
| 494 |
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.Genes Immun. 2011 Mar;12(2):110-5. doi: 10.1038/gene.2010.52. Epub 2010 Oct 14.
|
| 495 |
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.Genes Immun. 2012 Apr;13(3):253-7. doi: 10.1038/gene.2011.81. Epub 2011 Dec 1.
|
| 496 |
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms.Mult Scler. 2006 Feb;12(1):108-11. doi: 10.1191/135248506ms1249cr.
|
| 497 |
Unique T-cell receptor junctional sequences found in multiple sclerosis and T-cells mediating experimental allergic encephalomyelitis.Ann N Y Acad Sci. 1995 Jul 7;756:265-82. doi: 10.1111/j.1749-6632.1995.tb44524.x.
|
| 498 |
Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients.J Pineal Res. 2017 Nov;63(4). doi: 10.1111/jpi.12442. Epub 2017 Sep 6.
|
| 499 |
CYP27A1, CYP24A1, and RXR- Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study.J Mol Neurosci. 2018 Sep;66(1):77-84. doi: 10.1007/s12031-018-1152-9. Epub 2018 Aug 7.
|
| 500 |
Association of CYP2R1 rs10766197 with MS risk and disease progression.J Neurosci Res. 2018 Feb;96(2):297-304. doi: 10.1002/jnr.24133. Epub 2017 Aug 23.
|
| 501 |
Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.Neurosci Bull. 2013 Oct;29(5):525-30. doi: 10.1007/s12264-013-1347-6. Epub 2013 Jun 5.
|
| 502 |
SPG5 and multiple sclerosis: clinical and genetic overlap?.Acta Neurol Scand. 2016 Jun;133(6):410-4. doi: 10.1111/ane.12476. Epub 2015 Sep 15.
|
| 503 |
Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.Brain Behav Immun. 2015 Aug;48:313-25. doi: 10.1016/j.bbi.2015.04.013. Epub 2015 Apr 30.
|
| 504 |
Single nucleotide polymorphism (SNP)-strings: an alternative method for assessing genetic associations.PLoS One. 2014 Apr 11;9(4):e90034. doi: 10.1371/journal.pone.0090034. eCollection 2014.
|
| 505 |
Mouse metallothionein-1 and metallothionein-2 are not biologically interchangeable in an animal model of multiple sclerosis, EAE.Metallomics. 2019 Feb 20;11(2):327-337. doi: 10.1039/c8mt00285a.
|
| 506 |
Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants.Epidemiology. 2014 Jul;25(4):605-14. doi: 10.1097/EDE.0000000000000089.
|
| 507 |
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.Free Radic Biol Med. 2010 Nov 1;49(8):1283-9. doi: 10.1016/j.freeradbiomed.2010.07.013. Epub 2010 Jul 29.
|
| 508 |
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.Neurol Neurochir Pol. 2013 Jan-Feb;47(1):49-52. doi: 10.5114/ninp.2013.32935.
|
| 509 |
Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.Mult Scler. 2017 Nov;23(13):1707-1715. doi: 10.1177/1352458516684022. Epub 2016 Dec 22.
|
| 510 |
Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.Brain. 2009 May;132(Pt 5):1221-35. doi: 10.1093/brain/awp002. Epub 2009 Feb 13.
|
| 511 |
A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis.PLoS One. 2010 Nov 30;5(11):e14169. doi: 10.1371/journal.pone.0014169.
|
| 512 |
Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report.Mult Scler. 1998 Dec;4(6):490-6. doi: 10.1177/135245859800400606.
|
| 513 |
Interferon induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.Brain. 2013 Jun;136(Pt 6):1732-45. doi: 10.1093/brain/awt061. Epub 2013 Mar 21.
|
| 514 |
Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.J Neuroimmunol. 2002 May;126(1-2):213-20. doi: 10.1016/s0165-5728(02)00067-x.
|
| 515 |
Detection of two transforming growth factor-beta-related morphogens, bone morphogenetic proteins-4 and -5, in RNA of multiple sclerosis and Creutzfeldt-Jakob disease lesions.Acta Neuropathol. 1995;90(1):76-9. doi: 10.1007/BF00294462.
|
| 516 |
Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system.J Clin Endocrinol Metab. 2003 Jan;88(1):327-36. doi: 10.1210/jc.2002-020304.
|
| 517 |
Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia.J Neurosci Res. 1996 Aug 15;45(4):392-9. doi: 10.1002/(SICI)1097-4547(19960815)45:4<392::AID-JNR8>3.0.CO;2-4.
|
| 518 |
CD1b is expressed in multiple sclerosis lesions.J Neuroimmunol. 1996 Jul;67(2):145-51. doi: 10.1016/0165-5728(96)00045-8.
|
| 519 |
High-resolution melting curve analysis of polymorphisms within CD58, CD226, HLA-G genes and association with multiple sclerosis susceptibility in a subset of Iranian population: a case-control study.Acta Neurol Belg. 2020 Jun;120(3):645-652. doi: 10.1007/s13760-018-0992-y. Epub 2018 Aug 20.
|
| 520 |
Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.Mol Neurobiol. 2019 Mar;56(3):2039-2056. doi: 10.1007/s12035-018-1207-5. Epub 2018 Jul 8.
|
| 521 |
Antibodies to bovine beta-casein in diabetes and other autoimmune diseases.Horm Metab Res. 2002 Aug;34(8):455-9. doi: 10.1055/s-2002-33595.
|
| 522 |
Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis.Brain Res Mol Brain Res. 2003 Nov 26;119(2):170-83. doi: 10.1016/j.molbrainres.2003.09.008.
|
| 523 |
Single strand conformation analysis of two genes contained within the first intron of the neurofibromatosis type I gene in patients with multiple sclerosis.Neuropathol Appl Neurobiol. 1995 Jun;21(3):201-7. doi: 10.1111/j.1365-2990.1995.tb01051.x.
|
| 524 |
Prediction of response to interferon therapy in multiple sclerosis.Acta Neurol Scand. 2014 Oct;130(4):268-75. doi: 10.1111/ane.12269. Epub 2014 Jun 18.
|
| 525 |
Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000.J Antimicrob Chemother. 2002 May;49(5):785-92. doi: 10.1093/jac/dkf033.
|
| 526 |
Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.Autoimmunity. 2010 Dec;43(8):690-7. doi: 10.3109/08916930903567492.
|
| 527 |
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.Proc Natl Acad Sci U S A. 1984 Mar;81(6):1774-8. doi: 10.1073/pnas.81.6.1774.
|
| 528 |
Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions.Proc Natl Acad Sci U S A. 1992 May 15;89(10):4588-92. doi: 10.1073/pnas.89.10.4588.
|
| 529 |
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.Nat Med. 2002 May;8(5):500-8. doi: 10.1038/nm0502-500.
|
| 530 |
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.Mult Scler. 2014 Jun;20(7):812-21. doi: 10.1177/1352458513508836. Epub 2013 Oct 21.
|
| 531 |
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis.J Neuroimmunol. 1997 Dec;80(1-2):76-86. doi: 10.1016/s0165-5728(97)00136-7.
|
| 532 |
TAP 1 and TAP 2 transporter gene polymorphisms in multiple sclerosis: no evidence for disease association with TAP.J Neuroimmunol. 1994 Oct;54(1-2):35-40. doi: 10.1016/0165-5728(94)90228-3.
|
| 533 |
Seeing function in structure: "incidental" eye findings on OCT in a patient with multiple sclerosis.Mult Scler Relat Disord. 2019 Jun;31:72-73. doi: 10.1016/j.msard.2019.03.019. Epub 2019 Mar 28.
|
| 534 |
PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.J Neurol. 2004 Sep;251(9):1085-8. doi: 10.1007/s00415-004-0485-1.
|
| 535 |
Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.Glia. 2001 Oct;36(1):68-77. doi: 10.1002/glia.1096.
|
| 536 |
Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.Curr Top Microbiol Immunol. 2008;321:85-100. doi: 10.1007/978-3-540-75203-5_4.
|
| 537 |
A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members.J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):788-91. doi: 10.1136/jnnp.71.6.788.
|
| 538 |
Decreased interferon- induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.Acta Neurol Scand. 2017 Sep;136(3):233-238. doi: 10.1111/ane.12715. Epub 2016 Dec 5.
|
| 539 |
Drak2 is not required for tumor surveillance and suppression.Int Immunol. 2015 Mar;27(3):161-6. doi: 10.1093/intimm/dxu146. Epub 2015 Jan 7.
|
| 540 |
Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease.Adv Exp Med Biol. 2000;477:155-60. doi: 10.1007/0-306-46826-3_17.
|
| 541 |
Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.J Neuroimmunol. 2005 Jul;164(1-2):140-7. doi: 10.1016/j.jneuroim.2005.04.005.
|
| 542 |
Investigation on mitochondrial tRNA(Leu/Lys), NDI and ATPase 6/8 in Iranian multiple sclerosis patients.Cell Mol Neurobiol. 2007 Sep;27(6):695-700. doi: 10.1007/s10571-007-9160-2. Epub 2007 Jul 6.
|
| 543 |
The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.Acta Neurol Scand. 2007 Oct;116(4):231-4. doi: 10.1111/j.1600-0404.2007.00884.x.
|
| 544 |
The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.Genes Immun. 2006 Jun;7(4):327-34. doi: 10.1038/sj.gene.6364303. Epub 2006 Apr 27.
|
| 545 |
Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?.Br J Dermatol. 2005 Mar;152(3):537-40. doi: 10.1111/j.1365-2133.2004.06338.x.
|
| 546 |
Early B-cell Factor gene association with multiple sclerosis in the Spanish population.BMC Neurol. 2005 Oct 28;5:19. doi: 10.1186/1471-2377-5-19.
|
| 547 |
Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.Eur J Immunogenet. 2004 Jun;31(3):133-40. doi: 10.1111/j.1365-2370.2004.00456.x.
|
| 548 |
A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant.Neuromolecular Med. 2007;9(4):335-9. doi: 10.1007/s12017-007-8014-x. Epub 2007 Oct 13.
|
| 549 |
Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera.Scand J Immunol. 2006 Sep;64(3):325-35. doi: 10.1111/j.1365-3083.2006.01821.x.
|
| 550 |
Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin.Mult Scler. 2004 Apr;10(2):153-7. doi: 10.1191/1352458504ms998oa.
|
| 551 |
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.J Neuroimmunol. 2006 Oct;179(1-2):108-16. doi: 10.1016/j.jneuroim.2006.06.003. Epub 2006 Aug 24.
|
| 552 |
Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4.FEBS Lett. 2006 Jan 23;580(2):545-52. doi: 10.1016/j.febslet.2005.12.067. Epub 2005 Dec 29.
|
| 553 |
Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.Scand J Immunol. 2006 Oct;64(4):412-9. doi: 10.1111/j.1365-3083.2006.01796.x.
|
| 554 |
Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis.J Immunol. 2006 Oct 15;177(8):5652-8. doi: 10.4049/jimmunol.177.8.5652.
|
| 555 |
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients.J Neuroinflammation. 2019 Jun 27;16(1):131. doi: 10.1186/s12974-019-1526-0.
|
| 556 |
Ecotropic Viral Integration Site 5 (EVI5) variants are associated with multiple sclerosis in Iranian population.Mult Scler Relat Disord. 2017 Nov;18:15-19. doi: 10.1016/j.msard.2017.09.011. Epub 2017 Sep 14.
|
| 557 |
Successful treatment of metachromatic leukodystrophy using bone marrow transplantation of HoxB4 overexpressing cells.Mol Ther. 2010 Jul;18(7):1373-8. doi: 10.1038/mt.2010.74. Epub 2010 Apr 27.
|
| 558 |
The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factor.Immunobiology. 2020 Jan;225(1):151864. doi: 10.1016/j.imbio.2019.10.013. Epub 2019 Nov 5.
|
| 559 |
Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.J Mol Neurosci. 2018 Apr;64(4):543-550. doi: 10.1007/s12031-018-1058-6. Epub 2018 Mar 14.
|
| 560 |
LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis.J Exp Med. 2017 Jan;214(1):209-226. doi: 10.1084/jem.20160068.
|
| 561 |
Polymerase-1 pathway activation in acute multiple sclerosis relapse.Autoimmun Rev. 2018 Dec;17(12):1235-1239. doi: 10.1016/j.autrev.2018.07.006. Epub 2018 Oct 11.
|
| 562 |
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.Neurol Sci. 2018 Jan;39(1):97-102. doi: 10.1007/s10072-017-3148-6. Epub 2017 Oct 19.
|
| 563 |
Development of a Selective Inhibitor of Protein Arginine Deiminase 2.J Med Chem. 2017 Apr 13;60(7):3198-3211. doi: 10.1021/acs.jmedchem.7b00274. Epub 2017 Mar 31.
|
| 564 |
RGC-32 and diseases: the first 20years.Immunol Res. 2019 Jun;67(2-3):267-279. doi: 10.1007/s12026-019-09080-0.
|
| 565 |
ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics.Curr Top Med Chem. 2019;19(10):795-811. doi: 10.2174/1568026619666190412121811.
|
| 566 |
Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.Neurology. 2019 Jan 28;92(5):e406-e417. doi: 10.1212/WNL.0000000000006854.
|
| 567 |
A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project.Mult Scler Relat Disord. 2020 Feb;38:101524. doi: 10.1016/j.msard.2019.101524. Epub 2019 Nov 14.
|
| 568 |
Using mixed methods case-series evaluation in the development of a guided self-management hybrid CBT and ACT intervention for multiple sclerosis pain.Disabil Rehabil. 2017 Sep;39(18):1785-1798. doi: 10.1080/09638288.2016.1209580. Epub 2016 Aug 24.
|
| 569 |
The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: A review.Life Sci. 2019 May 1;224:33-40. doi: 10.1016/j.lfs.2019.03.045. Epub 2019 Mar 20.
|
| 570 |
Myxovirus resistance protein A (MxA) polymorphism is associated with IFN response in Iranian multiple sclerosis patients.Neurol Sci. 2017 Jun;38(6):1093-1099. doi: 10.1007/s10072-017-2935-4. Epub 2017 Apr 6.
|
| 571 |
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults.Mult Scler Relat Disord. 2018 Jan;19:161-165. doi: 10.1016/j.msard.2017.10.008. Epub 2017 Oct 14.
|
| 572 |
Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship.Sci Rep. 2017 Nov 6;7(1):14589. doi: 10.1038/s41598-017-14788-w.
|
| 573 |
Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.Mediators Inflamm. 2018 Apr 17;2018:1549549. doi: 10.1155/2018/1549549. eCollection 2018.
|
| 574 |
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.Nat Commun. 2016 Apr 13;7:11350. doi: 10.1038/ncomms11350.
|
| 575 |
Multiple sclerosis animal models: a clinical and histopathological perspective.Brain Pathol. 2017 Mar;27(2):123-137. doi: 10.1111/bpa.12454. Epub 2017 Jan 11.
|
| 576 |
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis.Dev Cell. 2018 Dec 3;47(5):592-607.e6. doi: 10.1016/j.devcel.2018.11.010.
|
| 577 |
AMIGO2 modulates T cell functions and its deficiency in mice ameliorates experimental autoimmune encephalomyelitis.Brain Behav Immun. 2017 May;62:110-123. doi: 10.1016/j.bbi.2017.01.009. Epub 2017 Feb 1.
|
| 578 |
Asymmetry of Brain Excitability: A New Biomarker that Predicts Objective and Subjective Symptoms in Multiple Sclerosis.Behav Brain Res. 2019 Feb 1;359:281-291. doi: 10.1016/j.bbr.2018.11.005. Epub 2018 Nov 6.
|
| 579 |
Interactome of the Autoimmune Risk Protein ANKRD55.Front Immunol. 2019 Sep 18;10:2067. doi: 10.3389/fimmu.2019.02067. eCollection 2019.
|
| 580 |
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16955-16960. doi: 10.1073/pnas.1902623116. Epub 2019 Aug 2.
|
| 581 |
A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.
|
| 582 |
Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.Glia. 2015 Oct;63(10):1840-9. doi: 10.1002/glia.22848. Epub 2015 May 6.
|
| 583 |
Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.PLoS One. 2018 Aug 16;13(8):e0202530. doi: 10.1371/journal.pone.0202530. eCollection 2018.
|
| 584 |
Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis.J Neuroinflammation. 2018 Sep 19;15(1):270. doi: 10.1186/s12974-018-1290-6.
|
| 585 |
JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.J Neurovirol. 2017 Apr;23(2):226-238. doi: 10.1007/s13365-016-0492-x. Epub 2016 Nov 3.
|
| 586 |
Protective C allele of the single-nucleotide polymorphism rs1335532 is associated with strong binding of Ascl2 transcription factor and elevated CD58 expression in B-cells.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3211-3220. doi: 10.1016/j.bbadis.2018.07.008. Epub 2018 Jul 10.
|
| 587 |
Genomewide admixture study in Mexican Mestizos with multiple sclerosis.Clin Neurol Neurosurg. 2015 Mar;130:55-60. doi: 10.1016/j.clineuro.2014.11.026. Epub 2014 Dec 24.
|
| 588 |
Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology.Neurosci Lett. 2014 Mar 6;562:34-8. doi: 10.1016/j.neulet.2013.12.070. Epub 2014 Jan 7.
|
| 589 |
Contribution of Plasma Membrane Calcium ATPases to neuronal maladaptive responses: Focus on spinal nociceptive mechanisms and neurodegeneration.Neurosci Lett. 2018 Jan 10;663:60-65. doi: 10.1016/j.neulet.2017.08.003. Epub 2017 Aug 2.
|
| 590 |
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.Clin Immunol. 2008 Oct;129(1):31-5. doi: 10.1016/j.clim.2008.07.011. Epub 2008 Aug 16.
|
| 591 |
Renin-angiotensin system gene expression and neurodegenerative diseases.J Renin Angiotensin Aldosterone Syst. 2016 Sep 9;17(3):1470320316666750. doi: 10.1177/1470320316666750. Print 2016 Jul.
|
| 592 |
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.Nat Med. 2014 Oct;20(10):1147-56. doi: 10.1038/nm.3681. Epub 2014 Sep 14.
|
| 593 |
Balanced Bcl-3 expression in murine CD4(+) Tcells is required for generation of encephalitogenic Th17 cells.Eur J Immunol. 2017 Aug;47(8):1335-1341. doi: 10.1002/eji.201746933. Epub 2017 Jun 29.
|
| 594 |
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.PLoS One. 2013;8(3):e58352. doi: 10.1371/journal.pone.0058352. Epub 2013 Mar 5.
|
| 595 |
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.J Neuroinflammation. 2016 Jun 22;13(1):161. doi: 10.1186/s12974-016-0611-x.
|
| 596 |
Plasma levels of CTRP-3, CTRP-9 and apelin in women with multiple sclerosis.J Neuroimmunol. 2019 Aug 15;333:576968. doi: 10.1016/j.jneuroim.2019.576968. Epub 2019 May 16.
|
| 597 |
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.Genes Immun. 2014 Mar;15(2):126-32. doi: 10.1038/gene.2013.70. Epub 2014 Jan 16.
|
| 598 |
Calnexin is necessary for T cell transmigration into the central nervous system.JCI Insight. 2018 Mar 8;3(5):e98410. doi: 10.1172/jci.insight.98410.
|
| 599 |
Release of interleukin-10 and neurotrophic factors in the choroid plexus: possible inductors of neurogenesis following copolymer-1 immunization after cerebral ischemia.Neural Regen Res. 2018 Oct;13(10):1743-1752. doi: 10.4103/1673-5374.238615.
|
| 600 |
Elastic net-based prediction of IFN- treatment response of patients with multiple sclerosis using time series microarray gene expression profiles.Sci Rep. 2019 Feb 12;9(1):1822. doi: 10.1038/s41598-018-38441-2.
|
| 601 |
CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.Brain Behav Immun. 2018 Jul;71:158-168. doi: 10.1016/j.bbi.2018.03.015. Epub 2018 Mar 14.
|
| 602 |
The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.Virol J. 2017 Dec 4;14(1):234. doi: 10.1186/s12985-017-0902-6.
|
| 603 |
CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis.J Neuroimmunol. 2019 Aug 15;333:576967. doi: 10.1016/j.jneuroim.2019.576967. Epub 2019 May 16.
|
| 604 |
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients.Front Immunol. 2017 May 18;8:531. doi: 10.3389/fimmu.2017.00531. eCollection 2017.
|
| 605 |
Expression of CD1d by astrocytes corresponds with relative activity in multiple sclerosis lesions.Brain Pathol. 2020 Jan;30(1):26-35. doi: 10.1111/bpa.12733. Epub 2019 Jun 6.
|
| 606 |
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages.Front Cell Neurosci. 2017 May 4;11:129. doi: 10.3389/fncel.2017.00129. eCollection 2017.
|
| 607 |
Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis.Sci Rep. 2017 Oct 19;7(1):13544. doi: 10.1038/s41598-017-12881-8.
|
| 608 |
Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.J Immunol. 2016 Oct 15;197(8):3038-3048. doi: 10.4049/jimmunol.1600706. Epub 2016 Aug 31.
|
| 609 |
Clinical and experimental evidence for targeting CD6 in immune-based disorders.Autoimmun Rev. 2018 May;17(5):493-503. doi: 10.1016/j.autrev.2017.12.004. Epub 2018 Mar 9.
|
| 610 |
Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.Metab Brain Dis. 2017 Feb;32(1):19-34. doi: 10.1007/s11011-016-9923-x. Epub 2016 Nov 2.
|
| 611 |
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.J Immunol. 1998 Jul 15;161(2):1034-44.
|
| 612 |
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.Int J Mol Sci. 2015 Sep 30;16(10):23463-81. doi: 10.3390/ijms161023463.
|
| 613 |
KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions.Glycobiology. 2018 Dec 1;28(12):958-967. doi: 10.1093/glycob/cwy064.
|
| 614 |
Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils.Brain Behav Immun. 2015 May;46:280-92. doi: 10.1016/j.bbi.2015.02.010. Epub 2015 Feb 16.
|
| 615 |
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.Immunol Cell Biol. 2015 Oct;93(9):825-36. doi: 10.1038/icb.2015.47. Epub 2015 Apr 2.
|
| 616 |
Intravitreal S100B Injection Leads to Progressive Glaucoma Like Damage in Retina and Optic Nerve.Front Cell Neurosci. 2018 Sep 26;12:312. doi: 10.3389/fncel.2018.00312. eCollection 2018.
|
| 617 |
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.J Neuroimmunol. 2016 Feb 15;291:70-2. doi: 10.1016/j.jneuroim.2015.12.014. Epub 2015 Dec 31.
|
| 618 |
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.Proteomics. 2015 Oct;15(19):3361-9. doi: 10.1002/pmic.201400142. Epub 2015 Sep 8.
|
| 619 |
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.Mult Scler. 2019 Oct;25(11):1444-1451. doi: 10.1177/1352458518794308. Epub 2018 Aug 16.
|
| 620 |
The cost of a catheter: An environmental perspective on single use clean intermittent catheterization.Neurourol Urodyn. 2018 Sep;37(7):2204-2208. doi: 10.1002/nau.23562. Epub 2018 Aug 14.
|
| 621 |
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.Neurology. 2019 Nov 12;93(20):e1852-e1866. doi: 10.1212/WNL.0000000000008466. Epub 2019 Oct 14.
|
| 622 |
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.Acta Neuropathol. 2014 Aug;128(2):267-77. doi: 10.1007/s00401-013-1227-1. Epub 2013 Dec 20.
|
| 623 |
Claudin-5: gatekeeper of neurological function.Fluids Barriers CNS. 2019 Jan 29;16(1):3. doi: 10.1186/s12987-019-0123-z.
|
| 624 |
Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy.Immunol Invest. 2018 Feb;47(2):135-145. doi: 10.1080/08820139.2017.1405978. Epub 2017 Nov 28.
|
| 625 |
Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.Brain Pathol. 2020 Jan;30(1):106-119. doi: 10.1111/bpa.12760. Epub 2019 Jul 23.
|
| 626 |
C-type lectin receptors Mcl and Mincle control development of multiple sclerosis-like neuroinflammation.J Clin Invest. 2020 Feb 3;130(2):838-852. doi: 10.1172/JCI125857.
|
| 627 |
Brief Report: Anti-Calponin 3 Autoantibodies: A Newly Identified Specificity in Patients With Sjgren's Syndrome.Arthritis Rheumatol. 2018 Oct;70(10):1610-1616. doi: 10.1002/art.40550. Epub 2018 Sep 3.
|
| 628 |
Differential modulation of the juxtaparanodal complex in Multiple Sclerosis.Mol Cell Neurosci. 2015 Jul;67:93-103. doi: 10.1016/j.mcn.2015.06.005. Epub 2015 Jun 10.
|
| 629 |
BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer's Disease than in Bullous Pemphigoid.J Invest Dermatol. 2019 Feb;139(2):293-299. doi: 10.1016/j.jid.2018.09.010. Epub 2018 Oct 10.
|
| 630 |
Scavenger receptor collectin placenta 1 is a novel receptor involved in the uptake of myelin by phagocytes.Sci Rep. 2017 Mar 20;7:44794. doi: 10.1038/srep44794.
|
| 631 |
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.Sci Rep. 2019 Sep 16;9(1):13299. doi: 10.1038/s41598-019-49868-6.
|
| 632 |
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.Genes Immun. 2017 Jan;18(1):48-56. doi: 10.1038/gene.2016.49. Epub 2017 Jan 5.
|
| 633 |
Chondroitin sulfate -1,4-N-acetylgalactosaminyltransferase-1 (ChGn-1) polymorphism: Association with progression of multiple sclerosis.Neurosci Res. 2016 Jul;108:55-9. doi: 10.1016/j.neures.2016.01.002. Epub 2016 Jan 20.
|
| 634 |
Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.J Neurochem. 2019 Feb;148(3):413-425. doi: 10.1111/jnc.14581. Epub 2018 Dec 3.
|
| 635 |
A Novel Regulatory Function of Long Non-coding RNAs at Different Levels of Gene Expression in Multiple Sclerosis.J Mol Neurosci. 2019 Mar;67(3):434-440. doi: 10.1007/s12031-018-1248-2. Epub 2019 Jan 4.
|
| 636 |
A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis.J Neuroinflammation. 2017 May 10;14(1):103. doi: 10.1186/s12974-017-0874-x.
|
| 637 |
Neuronal vulnerability and multilineage diversity in multiple sclerosis.Nature. 2019 Sep;573(7772):75-82. doi: 10.1038/s41586-019-1404-z. Epub 2019 Jul 17.
|
| 638 |
The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.J Neurol. 2014 Aug;261(8):1544-51. doi: 10.1007/s00415-014-7379-7. Epub 2014 May 23.
|
| 639 |
Increased CD74 binding and EAE treatment efficacy of a modified DR1 molecular construct.Metab Brain Dis. 2019 Feb;34(1):153-164. doi: 10.1007/s11011-018-0331-2. Epub 2018 Oct 23.
|
| 640 |
Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.Cell. 2017 Mar 23;169(1):72-84.e13. doi: 10.1016/j.cell.2017.03.007.
|
| 641 |
The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.Iran J Allergy Asthma Immunol. 2019 Jun 8;18(3):230-250. doi: 10.18502/ijaai.v18i3.1117.
|
| 642 |
Early Detection of Biofouling on Water Purification Membranes by Ambient Ionization Mass Spectrometry Imaging.Anal Chem. 2018 Jan 2;90(1):988-997. doi: 10.1021/acs.analchem.7b04236. Epub 2017 Dec 20.
|
| 643 |
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.Genes Immun. 2013 Jan;14(1):62-6. doi: 10.1038/gene.2012.52. Epub 2012 Nov 15.
|
| 644 |
Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.J Clin Neurosci. 2015 Jan;22(1):200-3. doi: 10.1016/j.jocn.2014.06.106. Epub 2014 Oct 30.
|
| 645 |
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.J Neuroimmunol. 2014 Dec 15;277(1-2):140-4. doi: 10.1016/j.jneuroim.2014.09.015. Epub 2014 Sep 28.
|
| 646 |
Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.J Neuropathol Exp Neurol. 1997 Jan;56(1):10-20. doi: 10.1097/00005072-199701000-00002.
|
| 647 |
Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years.Mult Scler Relat Disord. 2018 Oct;25:57-60. doi: 10.1016/j.msard.2018.07.012. Epub 2018 Jul 9.
|
| 648 |
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: beneficial effects in experimental autoimmune encephalomyelitis.BMC Complement Altern Med. 2013 Jun 28;13:149. doi: 10.1186/1472-6882-13-149.
|
| 649 |
Dynamics of Dynamin-Related Protein 1 in Alzheimer's Disease and Other Neurodegenerative Diseases.Cells. 2019 Aug 23;8(9):961. doi: 10.3390/cells8090961.
|
| 650 |
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.Neurosci Lett. 2012 Nov 21;530(2):155-60. doi: 10.1016/j.neulet.2012.10.008. Epub 2012 Oct 13.
|
| 651 |
Low DPP4 expression and activity in multiple sclerosis.Clin Immunol. 2014 Feb;150(2):170-83. doi: 10.1016/j.clim.2013.11.011. Epub 2013 Nov 28.
|
| 652 |
Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach.PLoS One. 2012;7(7):e40457. doi: 10.1371/journal.pone.0040457. Epub 2012 Jul 11.
|
| 653 |
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3-C/EBP pathway.Nat Commun. 2015 Sep 16;6:8272. doi: 10.1038/ncomms9272.
|
| 654 |
Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.J Neurol. 2019 Nov;266(11):2699-2709. doi: 10.1007/s00415-019-09476-w. Epub 2019 Jul 18.
|
| 655 |
Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link.Adv Exp Med Biol. 2017;958:57-64. doi: 10.1007/978-3-319-47861-6_5.
|
| 656 |
MS CD49d(+)CD154(+) Lymphocytes Reprogram Oligodendrocytes into Immune Reactive Cells Affecting CNS Regeneration.Cells. 2019 Nov 25;8(12):1508. doi: 10.3390/cells8121508.
|
| 657 |
Chromatin remodeler Ep400 ensures oligodendrocyte survival and is required for myelination in the vertebrate central nervous system.Nucleic Acids Res. 2019 Jul 9;47(12):6208-6224. doi: 10.1093/nar/gkz376.
|
| 658 |
Down-regulation of ERMN expression in relapsing remitting multiple sclerosis.Metab Brain Dis. 2019 Oct;34(5):1261-1266. doi: 10.1007/s11011-019-00429-w. Epub 2019 May 23.
|
| 659 |
Investigation of Endogenous Retrovirus Sequences in the Neighborhood of Genes Up-regulated in a Neuroblastoma Model after Treatment with Hypoxia-Mimetic Cobalt Chloride.Front Microbiol. 2018 Feb 21;9:287. doi: 10.3389/fmicb.2018.00287. eCollection 2018.
|
| 660 |
HERV-W env regulates calcium influx via activating TRPC3 channel together with depressing DISC1 in human neuroblastoma cells.J Neurovirol. 2019 Feb;25(1):101-113. doi: 10.1007/s13365-018-0692-7. Epub 2018 Nov 5.
|
| 661 |
Cladribine - an old newcomer for pulsed immune reconstitution in MS.Nat Rev Neurol. 2017 Oct;13(10):573-574. doi: 10.1038/nrneurol.2017.119. Epub 2017 Sep 8.
|
| 662 |
The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.Neuroscience. 2019 Jun 15;409:120-129. doi: 10.1016/j.neuroscience.2019.03.050. Epub 2019 Apr 30.
|
| 663 |
A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins.Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1718-26. doi: 10.1016/j.bbapap.2015.04.023. Epub 2015 Apr 30.
|
| 664 |
(18)F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis.J Nucl Med. 2020 May;61(5):757-763. doi: 10.2967/jnumed.119.229351. Epub 2019 Oct 25.
|
| 665 |
Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family.Mult Scler. 2019 Jun;25(7):909-917. doi: 10.1177/1352458518777202. Epub 2018 Jun 6.
|
| 666 |
Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis.J Neuroinflammation. 2017 Jun 23;14(1):123. doi: 10.1186/s12974-017-0900-z.
|
| 667 |
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population.Neurol Sci. 2015 Dec;36(12):2213-20. doi: 10.1007/s10072-015-2339-2. Epub 2015 Jul 21.
|
| 668 |
GAS8 and its naturally occurring antisense RNA as biomarkers in multiple sclerosis.Immunobiology. 2019 Jul;224(4):560-564. doi: 10.1016/j.imbio.2019.04.005. Epub 2019 Apr 13.
|
| 669 |
Branching enzyme deficiency: expanding the clinical spectrum.JAMA Neurol. 2014 Jan;71(1):41-7. doi: 10.1001/jamaneurol.2013.4888.
|
| 670 |
Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.Int J Neurosci. 2020 May;130(5):515-521. doi: 10.1080/00207454.2019.1695610. Epub 2019 Dec 2.
|
| 671 |
Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.Neuroscience. 2017 Sep 1;358:49-57. doi: 10.1016/j.neuroscience.2017.06.006. Epub 2017 Jun 20.
|
| 672 |
GPR65 inhibits experimental autoimmune encephalomyelitis through CD4(+) T cell independent mechanisms that include effects on iNKT cells.Immunol Cell Biol. 2018 Feb;96(2):128-136. doi: 10.1111/imcb.1031. Epub 2017 Dec 19.
|
| 673 |
Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis.J Neurochem. 2019 Feb;148(3):426-439. doi: 10.1111/jnc.14604. Epub 2018 Dec 3.
|
| 674 |
The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis.Int J Mol Sci. 2017 Mar 7;18(3):576. doi: 10.3390/ijms18030576.
|
| 675 |
Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6065-E6074. doi: 10.1073/pnas.1722041115. Epub 2018 Jun 12.
|
| 676 |
The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.J Neuroimmunol. 2019 Dec 15;337:577045. doi: 10.1016/j.jneuroim.2019.577045. Epub 2019 Aug 28.
|
| 677 |
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.PLoS One. 2016 Jan 28;11(1):e0147968. doi: 10.1371/journal.pone.0147968. eCollection 2016.
|
| 678 |
IL7R expression and upregulation by IFN in dendritic cell subsets is haplotype-dependent.PLoS One. 2013 Oct 16;8(10):e77508. doi: 10.1371/journal.pone.0077508. eCollection 2013.
|
| 679 |
Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE).J Neuroimmunol. 2018 May 15;318:56-64. doi: 10.1016/j.jneuroim.2018.02.008. Epub 2018 Mar 11.
|
| 680 |
Size-selected silver nanoparticles for MALDI-TOF mass spectrometry of amyloid-beta peptides.Nanoscale. 2018 Nov 29;10(46):22044-22054. doi: 10.1039/c8nr07921h.
|
| 681 |
Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9318-E9327. doi: 10.1073/pnas.1615715114. Epub 2017 Oct 16.
|
| 682 |
Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.Mult Scler. 2019 May;25(6):772-782. doi: 10.1177/1352458518770019. Epub 2018 Apr 23.
|
| 683 |
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.Nat Genet. 2009 Jul;41(7):776-82. doi: 10.1038/ng.401. Epub 2009 Jun 14.
|
| 684 |
Heat shock protein 70-hom gene polymorphism and protein expression in multiple sclerosis.J Neuroimmunol. 2016 Sep 15;298:189-93. doi: 10.1016/j.jneuroim.2016.07.011. Epub 2016 Jul 15.
|
| 685 |
Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration.Front Neurol. 2019 Mar 12;10:205. doi: 10.3389/fneur.2019.00205. eCollection 2019.
|
| 686 |
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by (1)H-NMR Spectroscopy.Neurotherapeutics. 2019 Jul;16(3):797-807. doi: 10.1007/s13311-019-00721-8.
|
| 687 |
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis.J Neuroimmunol. 2012 Apr;245(1-2):98-101. doi: 10.1016/j.jneuroim.2012.02.005. Epub 2012 Mar 2.
|
| 688 |
Theme 5 Human cell biology and pathology.Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):188-205. doi: 10.1080/21678421.2019.1646993.
|
| 689 |
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.J Neuroinflammation. 2018 Sep 14;15(1):265. doi: 10.1186/s12974-018-1307-1.
|
| 690 |
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.Mol Biol Rep. 2013 May;40(5):3731-7. doi: 10.1007/s11033-012-2449-3. Epub 2013 Mar 1.
|
| 691 |
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.Front Immunol. 2018 Apr 30;9:802. doi: 10.3389/fimmu.2018.00802. eCollection 2018.
|
| 692 |
IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.J Immunol. 2019 Aug 15;203(4):888-898. doi: 10.4049/jimmunol.1900400. Epub 2019 Jul 10.
|
| 693 |
Nerve conduction velocity is regulated by the inositol polyphosphate-4-phosphatase II gene.Am J Pathol. 2014 Sep;184(9):2420-9. doi: 10.1016/j.ajpath.2014.05.021. Epub 2014 Aug 13.
|
| 694 |
The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada.Mult Scler Relat Disord. 2017 Nov;18:218-224. doi: 10.1016/j.msard.2017.10.001. Epub 2017 Oct 6.
|
| 695 |
Common variation near IRF6 is associated with IFN--induced liver injury in multiple sclerosis.Nat Genet. 2018 Aug;50(8):1081-1085. doi: 10.1038/s41588-018-0168-y. Epub 2018 Jul 16.
|
| 696 |
The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.Respir Med. 2019 Mar;149:23-27. doi: 10.1016/j.rmed.2019.01.015. Epub 2019 Feb 1.
|
| 697 |
Indications for cellular migration from the central nervous system to its draining lymph nodes in CD11c-GFP(+) bone-marrow chimeras following EAE.Exp Brain Res. 2017 Jul;235(7):2151-2166. doi: 10.1007/s00221-017-4956-x. Epub 2017 Apr 18.
|
| 698 |
-Cyclodextrin-metal organic frameworks as efficient microcontainers for encapsulation of leflunomide and acceleration of its transformation into teriflunomide.Carbohydr Polym. 2019 Jul 15;216:224-230. doi: 10.1016/j.carbpol.2019.04.037. Epub 2019 Apr 9.
|
| 699 |
14-3-3 Proteins regulate K(2P) 5.1 surface expression on T lymphocytes.Traffic. 2017 Jan;18(1):29-43. doi: 10.1111/tra.12455. Epub 2016 Nov 27.
|
| 700 |
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.Acta Neuropathol Commun. 2014 Oct 3;2:144. doi: 10.1186/s40478-014-0144-4.
|
| 701 |
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Biol Chem. 2014 Sep;395(9):1063-73. doi: 10.1515/hsz-2014-0141.
|
| 702 |
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8(+) T cells involved in multiple sclerosis.J Autoimmun. 2018 Mar;88:61-74. doi: 10.1016/j.jaut.2017.10.005. Epub 2017 Oct 18.
|
| 703 |
Multiple sclerosis: Presence of serum antibodies to lipids and predominance of cholesterol recognition.J Neurosci Res. 2017 Oct;95(10):1984-1992. doi: 10.1002/jnr.24062. Epub 2017 May 8.
|
| 704 |
Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.PLoS One. 2017 Jun 26;12(6):e0177472. doi: 10.1371/journal.pone.0177472. eCollection 2017.
|
| 705 |
Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins.Int J Pharm. 2018 Jan 30;536(1):310-317. doi: 10.1016/j.ijpharm.2017.12.010. Epub 2017 Dec 5.
|
| 706 |
Silencing Leukocyte Immunoglobulin-Like Receptor A1 in Monocytes Inhibits Inflammation in Mice with Multiple Sclerosis.Neuroimmunomodulation. 2019;26(2):93-101. doi: 10.1159/000495625. Epub 2019 Jan 23.
|
| 707 |
Mutations in the lamin B1 gene are not present in multiple sclerosis.Eur J Neurol. 2009 Apr;16(4):544-6. doi: 10.1111/j.1468-1331.2009.02536.x.
|
| 708 |
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.JAMA Neurol. 2016 May 1;73(5):520-8. doi: 10.1001/jamaneurol.2015.4807.
|
| 709 |
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.Mol Neurobiol. 2017 Jan;54(1):101-114. doi: 10.1007/s12035-015-9665-5. Epub 2016 Jan 5.
|
| 710 |
Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.Mol Neurobiol. 2018 Dec;55(12):9307-9327. doi: 10.1007/s12035-018-1049-1. Epub 2018 Apr 17.
|
| 711 |
MRM-MS of marker peptides and their abundance as a tool for authentication of meat species and meat cuts in single-cut meat products.Food Chem. 2019 Jun 15;283:367-374. doi: 10.1016/j.foodchem.2019.01.007. Epub 2019 Jan 8.
|
| 712 |
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.J Neuroimmunol. 2013 Mar 15;256(1-2):71-6. doi: 10.1016/j.jneuroim.2012.12.008. Epub 2013 Jan 22.
|
| 713 |
Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.Tissue Antigens. 2008 Jul;72(1):54-9. doi: 10.1111/j.1399-0039.2008.01066.x.
|
| 714 |
A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.Nutrients. 2019 Jul 5;11(7):1528. doi: 10.3390/nu11071528.
|
| 715 |
Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis.PLoS One. 2009;4(3):e4952. doi: 10.1371/journal.pone.0004952. Epub 2009 Mar 20.
|
| 716 |
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.Genes Immun. 2010 Jul;11(5):397-405. doi: 10.1038/gene.2010.28. Epub 2010 Jun 17.
|
| 717 |
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.Genes Immun. 2019 Feb;20(2):167-171. doi: 10.1038/s41435-018-0017-0. Epub 2018 Mar 10.
|
| 718 |
Oligodendrocyte degeneration and concomitant microglia activation directs peripheral immune cells into the forebrain.Neurochem Int. 2019 Jun;126:139-153. doi: 10.1016/j.neuint.2019.03.005. Epub 2019 Mar 10.
|
| 719 |
Monodisperse magnetic poly(glycidyl methacrylate) microspheres for isolation of autoantibodies with affinity for the 46kDa form of unconventional Myo1C present in autoimmune patients.Mikrochim Acta. 2018 Apr 23;185(5):262. doi: 10.1007/s00604-018-2807-5.
|
| 720 |
Myelin regulatory factor drives remyelination in multiple sclerosis.Acta Neuropathol. 2017 Sep;134(3):403-422. doi: 10.1007/s00401-017-1741-7. Epub 2017 Jun 19.
|
| 721 |
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.Exp Brain Res. 2017 Jan;235(1):279-292. doi: 10.1007/s00221-016-4789-z. Epub 2016 Oct 5.
|
| 722 |
Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon -1b.J Interferon Cytokine Res. 2015 Mar;35(3):186-99. doi: 10.1089/jir.2014.0115. Epub 2014 Oct 20.
|
| 723 |
Variations in mitochondrial DNA copy numbers in MS brains.J Mol Neurosci. 2008 Jul;35(3):283-7. doi: 10.1007/s12031-008-9115-1. Epub 2008 Jun 20.
|
| 724 |
Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis.J Neurol Sci. 2015 Sep 15;356(1-2):55-60. doi: 10.1016/j.jns.2015.04.050. Epub 2015 May 7.
|
| 725 |
Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis.J Neurochem. 2018 Apr;145(2):139-153. doi: 10.1111/jnc.14294. Epub 2018 Feb 19.
|
| 726 |
Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.J Neuroimmunol. 2014 Apr 15;269(1-2):68-75. doi: 10.1016/j.jneuroim.2014.02.008. Epub 2014 Feb 25.
|
| 727 |
Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis.Brain. 2010 Feb;133(Pt 2):389-405. doi: 10.1093/brain/awp341. Epub 2010 Feb 3.
|
| 728 |
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.Eur J Immunol. 2015 May;45(5):1377-89. doi: 10.1002/eji.201444638. Epub 2015 Feb 19.
|
| 729 |
Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.Neurol Sci. 2019 Jun;40(6):1137-1144. doi: 10.1007/s10072-019-03780-z. Epub 2019 Feb 27.
|
| 730 |
A single nucleotide polymorphism within Ninjurin 2 is associated with risk of multiple sclerosis.Metab Brain Dis. 2019 Oct;34(5):1415-1419. doi: 10.1007/s11011-019-00460-x. Epub 2019 Jul 10.
|
| 731 |
Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis.Mult Scler Relat Disord. 2019 Apr;29:26-34. doi: 10.1016/j.msard.2019.01.023. Epub 2019 Jan 11.
|
| 732 |
Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin.Int J Mol Sci. 2019 Jan 3;20(1):154. doi: 10.3390/ijms20010154.
|
| 733 |
Serum NADPH oxidase concentrations and the associations with iron metabolism in relapsing remitting multiple sclerosis.J Trace Elem Med Biol. 2019 Sep;55:39-43. doi: 10.1016/j.jtemb.2019.05.011. Epub 2019 May 25.
|
| 734 |
Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy.J Proteome Res. 2017 Mar 3;16(3):1300-1314. doi: 10.1021/acs.jproteome.6b00916. Epub 2017 Feb 9.
|
| 735 |
Interleukin 1 receptor antagonist and 2'-5'-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain.Mult Scler Relat Disord. 2017 Nov;18:1-7. doi: 10.1016/j.msard.2017.09.001. Epub 2017 Sep 8.
|
| 736 |
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.Mult Scler. 2010 Mar;16(3):293-302. doi: 10.1177/1352458509358189.
|
| 737 |
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.Dis Markers. 2014;2014:362708. doi: 10.1155/2014/362708. Epub 2014 Apr 16.
|
| 738 |
Identification of a novel Parkinson's disease locus via stratified genome-wide association study.BMC Genomics. 2014 Feb 10;15:118. doi: 10.1186/1471-2164-15-118.
|
| 739 |
Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.JAMA Neurol. 2017 May 1;74(5):574-582. doi: 10.1001/jamaneurol.2016.5131.
|
| 740 |
Association Between Exposure of Ipratropium and Salmeterol and Diagnosis of Multiple Sclerosis: A Matched Case-control Study.Clin Ther. 2019 Aug;41(8):1477-1485. doi: 10.1016/j.clinthera.2019.04.039. Epub 2019 May 23.
|
| 741 |
OTUB1 inhibits CNS autoimmunity by preventing IFN--induced hyperactivation of astrocytes.EMBO J. 2019 May 15;38(10):e100947. doi: 10.15252/embj.2018100947. Epub 2019 Apr 3.
|
| 742 |
Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis.J Immunol. 2016 May 15;196(10):4338-47. doi: 10.4049/jimmunol.1502440. Epub 2016 Apr 13.
|
| 743 |
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis.Eur J Neurol. 2020 Feb;27(2):235-243. doi: 10.1111/ene.14058. Epub 2019 Sep 8.
|
| 744 |
Iron Drives T Helper Cell Pathogenicity by Promoting RNA-Binding Protein PCBP1-Mediated Proinflammatory Cytokine Production.Immunity. 2018 Jul 17;49(1):80-92.e7. doi: 10.1016/j.immuni.2018.05.008. Epub 2018 Jun 26.
|
| 745 |
Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade.Front Mol Neurosci. 2018 Sep 13;11:333. doi: 10.3389/fnmol.2018.00333. eCollection 2018.
|
| 746 |
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.Genome Med. 2019 Apr 30;11(1):26. doi: 10.1186/s13073-019-0640-z.
|
| 747 |
PER3 VNTR polymorphism in Multiple Sclerosis: A new insight to impact of sleep disturbances in MS.Mult Scler Relat Disord. 2017 Oct;17:84-86. doi: 10.1016/j.msard.2017.07.005. Epub 2017 Jul 5.
|
| 748 |
Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.Neurol Res. 2017 Apr;39(4):323-330. doi: 10.1080/01616412.2016.1275460. Epub 2017 Feb 13.
|
| 749 |
PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients.Neuromolecular Med. 2017 Sep;19(2-3):286-292. doi: 10.1007/s12017-017-8443-0. Epub 2017 May 23.
|
| 750 |
Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis.J Neuroimmunol. 2020 Jan 15;338:577090. doi: 10.1016/j.jneuroim.2019.577090. Epub 2019 Oct 26.
|
| 751 |
Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.Neuroimage Clin. 2019;23:101879. doi: 10.1016/j.nicl.2019.101879. Epub 2019 May 29.
|
| 752 |
A computational approach based on the colored Petri net formalism for studying multiple sclerosis.BMC Bioinformatics. 2019 Dec 10;20(Suppl 6):623. doi: 10.1186/s12859-019-3196-4.
|
| 753 |
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.Acta Neuropathol Commun. 2014 Dec 10;2:170. doi: 10.1186/s40478-014-0170-2.
|
| 754 |
Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.Blood. 2013 Jan 24;121(4):595-603. doi: 10.1182/blood-2012-07-440339. Epub 2012 Nov 16.
|
| 755 |
Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.J Immunol. 2017 Dec 1;199(11):3748-3756. doi: 10.4049/jimmunol.1700667. Epub 2017 Oct 23.
|
| 756 |
Synthesis and Biological Evaluation of FTY720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents.Chem Pharm Bull (Tokyo). 2018;66(10):1015-1018. doi: 10.1248/cpb.c18-00065.
|
| 757 |
Abnormal task driven neural oscillations in multiple sclerosis: A visuomotor MEG study.Hum Brain Mapp. 2017 May;38(5):2441-2453. doi: 10.1002/hbm.23531. Epub 2017 Feb 27.
|
| 758 |
QKI-V5 is downregulated in CNS inflammatory demyelinating diseases.Mult Scler Relat Disord. 2020 Apr;39:101881. doi: 10.1016/j.msard.2019.101881. Epub 2019 Dec 4.
|
| 759 |
Homodimer Architecture of QTRT2, the Noncatalytic Subunit of the Eukaryotic tRNA-Guanine Transglycosylase.Biochemistry. 2018 Jul 3;57(26):3953-3965. doi: 10.1021/acs.biochem.8b00294. Epub 2018 Jun 14.
|
| 760 |
Revealing the functions of novel mutations in RAB3GAP1 in Martsolf and Warburg micro syndromes.Am J Med Genet A. 2019 Apr;179(4):579-587. doi: 10.1002/ajmg.a.61065. Epub 2019 Feb 7.
|
| 761 |
Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.AIDS Res Hum Retroviruses. 2015 Feb;31(2):242-9. doi: 10.1089/AID.2014.0171. Epub 2014 Nov 19.
|
| 762 |
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.Sci Rep. 2019 Aug 12;9(1):11664. doi: 10.1038/s41598-019-48087-3.
|
| 763 |
Does the radiologically isolated syndrome exist? A dual-task cost pilot study.Neurol Sci. 2017 Nov;38(11):2007-2013. doi: 10.1007/s10072-017-3094-3. Epub 2017 Aug 22.
|
| 764 |
Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells.Mult Scler. 2019 Jan;25(1):63-71. doi: 10.1177/1352458517740213. Epub 2017 Nov 6.
|
| 765 |
Assessment of expression of RELN signaling pathway in multiple sclerosis patients.Immunobiology. 2019 May;224(3):402-407. doi: 10.1016/j.imbio.2019.02.007. Epub 2019 Feb 12.
|
| 766 |
Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.J Autoimmun. 2019 Jul;101:56-69. doi: 10.1016/j.jaut.2019.04.003. Epub 2019 Apr 19.
|
| 767 |
The application of strand invasion phenomenon, directed by peptide nucleic acid (PNA) and single-stranded DNA binding protein (SSB) for the recognition of specific sequences of human endogenous retroviral HERV-W family.J Mol Recognit. 2017 May;30(5). doi: 10.1002/jmr.2600. Epub 2016 Dec 6.
|
| 768 |
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.Mult Scler. 2014 May;20(6):675-85. doi: 10.1177/1352458513507819. Epub 2013 Oct 14.
|
| 769 |
Copy number variation in pediatric multiple sclerosis.Mult Scler. 2013 Jul;19(8):1014-21. doi: 10.1177/1352458512469696. Epub 2012 Dec 13.
|
| 770 |
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis.Mult Scler Relat Disord. 2020 Feb;38:101494. doi: 10.1016/j.msard.2019.101494. Epub 2019 Nov 5.
|
| 771 |
Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.PLoS One. 2018 Mar 8;13(3):e0193986. doi: 10.1371/journal.pone.0193986. eCollection 2018.
|
| 772 |
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.Mol Neurobiol. 2017 Aug;54(6):4820-4831. doi: 10.1007/s12035-016-0154-2. Epub 2016 Oct 6.
|
| 773 |
Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients.Sci Rep. 2019 Aug 19;9(1):11996. doi: 10.1038/s41598-019-48493-7.
|
| 774 |
CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis.Mult Scler. 2018 Mar;24(3):290-300. doi: 10.1177/1352458517698759. Epub 2017 Mar 9.
|
| 775 |
HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.Immunol Lett. 2020 Jan;217:15-24. doi: 10.1016/j.imlet.2019.10.017. Epub 2019 Nov 3.
|
| 776 |
Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.Mult Scler. 2016 May;22(6):733-40. doi: 10.1177/1352458515602338. Epub 2015 Sep 11.
|
| 777 |
SOX10 Single Transcription Factor-Based Fast and Efficient Generation ofOligodendrocytes from Human Pluripotent Stem Cells.Stem Cell Reports. 2018 Feb 13;10(2):655-672. doi: 10.1016/j.stemcr.2017.12.014. Epub 2018 Jan 11.
|
| 778 |
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.Brain. 2013 Jun;136(Pt 6):1778-82. doi: 10.1093/brain/awt101.
|
| 779 |
Sp3 expression in immune cells: a quantitative study.Lab Invest. 2002 Sep;82(9):1131-8. doi: 10.1097/01.lab.0000029149.38881.84.
|
| 780 |
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.Genome Med. 2011 Jan 18;3(1):3. doi: 10.1186/gm217.
|
| 781 |
A rare case of SPG11 mutation with multiple sclerosis.Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):389-91. doi: 10.1016/j.neurol.2016.03.006. Epub 2016 May 11.
|
| 782 |
Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation.Neuron. 2017 Dec 20;96(6):1290-1302.e6. doi: 10.1016/j.neuron.2017.11.032.
|
| 783 |
Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice.J Neurosci Res. 2020 Apr;98(4):704-717. doi: 10.1002/jnr.24554. Epub 2019 Nov 22.
|
| 784 |
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.Brain. 2010 Sep;133(9):2603-11. doi: 10.1093/brain/awq192.
|
| 785 |
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis.Brain Behav Immun. 2018 Feb;68:197-210. doi: 10.1016/j.bbi.2017.10.018. Epub 2017 Oct 21.
|
| 786 |
Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.Mult Scler. 2009 Jan;15(1):124-8. doi: 10.1177/1352458508096682. Epub 2008 Aug 28.
|
| 787 |
Association of rs1738074 polymorphism of TAGAP gene with susceptibility to multiple sclerosis in the Iranian population.Neurosci Lett. 2017 May 1;648:66-69. doi: 10.1016/j.neulet.2017.03.041. Epub 2017 Mar 27.
|
| 788 |
The three-dimensional structure of human transaldolase.FEBS Lett. 2000 Jun 23;475(3):205-8. doi: 10.1016/s0014-5793(00)01658-6.
|
| 789 |
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.Biochim Biophys Acta. 2014 Jul;1842(7):1130-6. doi: 10.1016/j.bbadis.2014.04.010. Epub 2014 Apr 13.
|
| 790 |
Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.PLoS One. 2016 Jul 20;11(7):e0158327. doi: 10.1371/journal.pone.0158327. eCollection 2016.
|
| 791 |
MicroRNA-590 promotes pathogenic Th17cell differentiation through targeting Tob1 and is associated with multiple sclerosis.Biochem Biophys Res Commun. 2017 Nov 18;493(2):901-908. doi: 10.1016/j.bbrc.2017.09.123. Epub 2017 Sep 23.
|
| 792 |
Increased level of plasma salusin- and salusin- in patients with multiple sclerosis.Mult Scler Relat Disord. 2019 May;30:76-80. doi: 10.1016/j.msard.2019.02.003. Epub 2019 Feb 5.
|
| 793 |
TERC promotes cellular inflammatory response independent of telomerase.Nucleic Acids Res. 2019 Sep 5;47(15):8084-8095. doi: 10.1093/nar/gkz584.
|
| 794 |
TRAF2 is upregulated in relapsing-remitting multiple sclerosis.Neuroimmunomodulation. 2013;20(3):177-83. doi: 10.1159/000346794. Epub 2013 Apr 5.
|
| 795 |
A genome-wide association study in progressive multiple sclerosis.Mult Scler. 2012 Oct;18(10):1384-94. doi: 10.1177/1352458512439118. Epub 2012 Mar 28.
|
| 796 |
Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis.Int J Mol Sci. 2019 Sep 4;20(18):4323. doi: 10.3390/ijms20184323.
|
| 797 |
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.PLoS One. 2018 Mar 27;13(3):e0194115. doi: 10.1371/journal.pone.0194115. eCollection 2018.
|
| 798 |
Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.Neuroimmunomodulation. 2010;17(2):120-5. doi: 10.1159/000258695. Epub 2009 Nov 17.
|
| 799 |
APOE genotypes in African American female multiple sclerosis patients.Neurosci Lett. 2007 Feb 27;414(1):51-6. doi: 10.1016/j.neulet.2006.12.049. Epub 2007 Jan 7.
|
| 800 |
Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice.J Neurosci. 2008 Oct 8;28(41):10330-8. doi: 10.1523/JNEUROSCI.2644-08.2008.
|
| 801 |
Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness.J Neurol Sci. 2011 Aug 15;307(1-2):127-31. doi: 10.1016/j.jns.2011.04.024. Epub 2011 May 24.
|
| 802 |
Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.J Neuroimmunol. 2011 Mar;232(1-2):179-85. doi: 10.1016/j.jneuroim.2010.09.030. Epub 2010 Nov 13.
|
| 803 |
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.Genes Immun. 2010 Mar;11(2):142-54. doi: 10.1038/gene.2009.82. Epub 2009 Oct 29.
|
| 804 |
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions.J Neuroimmunol. 2007 Oct;190(1-2):72-9. doi: 10.1016/j.jneuroim.2007.07.024. Epub 2007 Sep 6.
|
| 805 |
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.Brain. 2007 Feb;130(Pt 2):490-501. doi: 10.1093/brain/awl273. Epub 2006 Sep 26.
|
| 806 |
Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.J Med Chem. 2010 Feb 25;53(4):1741-54. doi: 10.1021/jm901652p.
|
| 807 |
Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability.Front Neurosci. 2019 Feb 11;13:86. doi: 10.3389/fnins.2019.00086. eCollection 2019.
|
| 808 |
CASP-9: A susceptibility locus for multiple sclerosis in Italy.J Neuroimmunol. 2009 May 29;210(1-2):100-3. doi: 10.1016/j.jneuroim.2009.03.013. Epub 2009 Apr 8.
|
| 809 |
CCL genes in multiple sclerosis and systemic lupus erythematosus.J Neuroimmunol. 2008 Aug 30;200(1-2):145-52. doi: 10.1016/j.jneuroim.2008.05.016. Epub 2008 Jul 3.
|
| 810 |
Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis.J Immunol. 2007 Sep 15;179(6):4074-82. doi: 10.4049/jimmunol.179.6.4074.
|
| 811 |
A novel mitochondrial DNA deletion producing progressive external ophthalmoplegia associated with multiple sclerosis.J Clin Neurosci. 2011 Oct;18(10):1318-24. doi: 10.1016/j.jocn.2011.02.019. Epub 2011 Jul 26.
|
| 812 |
DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis.J Med Genet. 2010 Jan;47(1):66-70. doi: 10.1136/jmg.2009.068221. Epub 2009 Jul 9.
|
| 813 |
Vitamin D-binding protein gene polymorphisms are not associated with MS risk in an Italian cohort.J Neuroimmunol. 2017 Apr 15;305:92-95. doi: 10.1016/j.jneuroim.2017.02.009. Epub 2017 Feb 8.
|
| 814 |
Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26.
|
| 815 |
Functional lesional neurosurgery for tremor: a systematic review and meta-analysis.J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):717-726. doi: 10.1136/jnnp-2017-316302. Epub 2018 Jan 11.
|
| 816 |
Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.J Immunol. 2011 Jul 15;187(2):781-90. doi: 10.4049/jimmunol.1100789. Epub 2011 Jun 10.
|
| 817 |
Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.Eur J Hum Genet. 2010 May;18(5):618-20. doi: 10.1038/ejhg.2009.213. Epub 2009 Nov 25.
|
| 818 |
Heat Shock Protein 70 and The Risk of Multiple Sclerosis in The Iranian Population.Cell J. 2019 Jan;20(4):599-603. doi: 10.22074/cellj.2019.5620. Epub 2018 Aug 1.
|
| 819 |
Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein.J Immunol. 2010 Aug 15;185(4):2458-66. doi: 10.4049/jimmunol.0902153. Epub 2010 Jul 19.
|
| 820 |
NRAMP1 (SLC11A1) variants: genetic susceptibility to multiple Sclerosis.J Clin Immunol. 2010 Jul;30(4):583-6. doi: 10.1007/s10875-010-9422-5. Epub 2010 Apr 20.
|
| 821 |
RNAi Screen and Proteomics Reveal NXF1 as a Novel Regulator of IRF5 Signaling.Sci Rep. 2017 Jun 2;7(1):2683. doi: 10.1038/s41598-017-02857-z.
|
| 822 |
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.Front Immunol. 2019 Oct 15;10:2403. doi: 10.3389/fimmu.2019.02403. eCollection 2019.
|
| 823 |
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.Oncotarget. 2016 Nov 8;7(45):72537-72545. doi: 10.18632/oncotarget.12345.
|
| 824 |
Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis.J Biol Chem. 2009 Oct 30;284(44):30615-26. doi: 10.1074/jbc.M109.041244. Epub 2009 Sep 2.
|
| 825 |
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.Nat Commun. 2011;2:334. doi: 10.1038/ncomms1333.
|
| 826 |
Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score.J Control Release. 2019 Apr 10;299:149-164. doi: 10.1016/j.jconrel.2019.02.032. Epub 2019 Feb 23.
|
| 827 |
Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.Glia. 2007 May;55(7):687-97. doi: 10.1002/glia.20492.
|
| 828 |
mtDNA nt13708A variant increases the risk of multiple sclerosis.PLoS One. 2008 Feb 13;3(2):e1530. doi: 10.1371/journal.pone.0001530.
|
| 829 |
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients.Genes Immun. 2011 Oct;12(7):523-30. doi: 10.1038/gene.2011.25. Epub 2011 Jun 9.
|
| 830 |
Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.Hum Genet. 2012 Jan;131(1):87-97. doi: 10.1007/s00439-011-1053-2. Epub 2011 Jul 7.
|
| 831 |
Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis.Folia Neuropathol. 2017;55(3):199-205. doi: 10.5114/fn.2017.70484.
|
| 832 |
Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue.Exp Brain Res. 2008 May;187(3):459-65. doi: 10.1007/s00221-008-1317-9. Epub 2008 Feb 23.
|
| 833 |
Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.J Mol Neurosci. 2007;32(3):169-78. doi: 10.1007/s12031-007-0018-3.
|
| 834 |
RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling.Trends Cell Biol. 2017 May;27(5):365-378. doi: 10.1016/j.tcb.2016.11.009. Epub 2016 Dec 19.
|
| 835 |
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.PLoS One. 2010 Apr 2;5(4):e10003. doi: 10.1371/journal.pone.0010003.
|
| 836 |
Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene.J Neuroimmunol. 2008 Jul 15;197(2):124-7. doi: 10.1016/j.jneuroim.2008.04.003. Epub 2008 Jun 3.
|
| 837 |
HLA and multiple sclerosis: population and families study.Tissue Antigens. 1985 Apr;25(4):187-99. doi: 10.1111/j.1399-0039.1985.tb00436.x.
|
| 838 |
Chipping away at diagnostics for neurodegenerative diseases.Neurobiol Dis. 2009 Aug;35(2):148-56. doi: 10.1016/j.nbd.2009.02.016. Epub 2009 Mar 10.
|
| 839 |
The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.J Neuroimmunol. 2007 Feb;183(1-2):208-13. doi: 10.1016/j.jneuroim.2006.11.002. Epub 2006 Dec 18.
|
| 840 |
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.Mult Scler. 2008 Apr;14(3):412-4. doi: 10.1177/1352458507083780. Epub 2008 Jan 21.
|
| 841 |
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.PLoS One. 2011;6(7):e21766. doi: 10.1371/journal.pone.0021766. Epub 2011 Jul 21.
|
| 842 |
TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.Neuropathol Appl Neurobiol. 2007 Feb;33(1):99-107. doi: 10.1111/j.1365-2990.2006.00787.x.
|
|
|
|
|
|
|
